YPB Signs 350 New Anti-Theft Retail Outlets

9th December 2016 – ASX Announcement 

Brand Protection and Customer Engagement solutions company YPB Group Limited (ASX: YPB) is pleased to provide an update on its Australian PROTECT anti-theft business.

In addition to previously announced customers, such as Dan Murphy’s and BWS which number around 2,200 retail stores, YPB’s solutions will now be implemented at up to 200 Lorna Jane stores across Australia and USA.

The Lorna Jane implementation will bring to around 350 stores the new stores PROTECTED by YPB and three new major chains across Australia, New Zealand and USA.

To view the full announcement, please click on the button below.

Folkestone Education Trust – December 2016 Quarter Distribution

9th December 2016

In accordance with the 2017 full year distribution guidance of 14.2 cents per unit (cpu), Folkestone Investment Management Limited as the responsible entity of the Folkestone Education Trust (FET) gives notice that the distribution for the quarter ending 31 December 2016 is 3.55 cpu.

The following dates apply to the distribution for the December 2016 quarter:

Ex-Distribution Date - 29 December 2016
Record Date - 30 December 2016
Payment Date - 20 January 2017
The Distribution Reinvestment Plan (DRP) will apply to this distribution with a discount of 1.5% to the average of the daily volume weighted average market price recorded on the ASX commencing on 4 January through to 17 January 2017.  Unitholders who have not yet participated in the DRP are required to complete and sign their application form and return it to FET’s registry, Boardroom Pty Limited by 4 January 2017 to participate in this quarter’s DRP.

USR – Renounceable Rights Issue

9th December 2016 – ASX Announcement

US Residential Fund (ASX: USR) (“USR”, “the Fund”) is pleased to advise that it is close to finalising a partially underwritten, renounceable rights issue to raise up to $8 million before costs and fees.

The rights issue will comprise one (1) new fully paid USR stapled security for every one (1) fully paid USR stapled security at a price of $0.45 per stapled security.

Funds from the Rights Issue will be used to fund USR’s investment in the Patriot’s Pointe multifamily apartment complex in North Carolina or investment in other multifamily assets in the US should the Patriot’s Pointe transaction not be finalised.

To view the full announcement, please click on the button below.

Folkestone Maxim A-REIT Securities Fund – November 2016 Monthly Report

November 2016
Over the 12 month period ended 30 November 2016, the Fund returned +11.87% (after fees, before tax), outperforming the Benchmark return of +10.31% by +1.56%.

The Monthly Report provides a snapshot of the Fund and the A-REIT sector’s performance.

The Folkestone Maxim A-REIT Securities Fund is a high conviction, actively managed fund, that gives investors exposure to a mix of quality listed A-REITs that own assets across the retail, residential, commercial, industrial and real estate related social infrastructure sectors.

  • Investment Expertise
  • Exposure to Listed Real Estate
  • High Conviction, Active Strategy
  • Daily Liquidity
  • Quarterly Distributions
  • Strategic Capacity Limit

 

iFAST Singapore Launches FSMOne

8th December 2016 - iFAST Corporation

iFAST Financial Pte Ltd (“iFAST Singapore”), the Singapore subsidiary of SGX-ST Mainboard-listed iFAST Corporation Ltd. (“iFAST Corp”), has launched the FSMOne account, on its Business-to-Consumer (B2C) platform, Fundsupermart.com (“FSM”) which caters to Do-It-Yourself (DIY) investors.

FSMOne allows the investors community in Singapore to invest seamlessly and in a transparent way, in multiple investment products including funds, bonds and insurance products, as well as new investment products and services including roboadvisory portfolios known as FSM MAPS (My Assisted Portfolio Solution), stocks and Exchange Traded Funds (ETFs).

To view the full announcement, please click on the button below.

Vinomofo Is Shaking Up the Online Wine Industry

7th December 2016 – Bloomberg 

Justin Dry, chief executive officer and co-founder of Vinomofo, discusses his online wine retail startup, who he’s targeting and where he’s seeing growth. He speaks to Bloomberg’s Haidi Lun and Rishaad Salamat on “Bloomberg Markets.”

About Vinomofo

Vinomofo is Australia’s leading online wine retail business founded in 2011. Since then the company has experienced rapid growth, currently generating run-rate revenue of more than $50m (p.a.) and having been profitable at the EBITDA level since inception. Vinomofo has a unique “cult-like” following and has achieved 400% growth over the last 2 years without significant investment in marketing.

Vinomofo differentiates itself from other online wine retailers through its ability to offer a very narrow range of quality wines, great value for money by sourcing directly from producers and by creating a community around wine that is different from the traditional wine industry, making wine more accessible to the average consumer. Key highlights include a track record of growth and profitability, attractive financial profile, strong founder team, clear Australian growth opportunities, international growth potential and a strong exit potential.

If you would like more information about Vinomofo, please click on the button below.

MedAdvisor Signs Pfizer for Patient Engagement Program

8th December 2016 – ASX Announcement 

  • MedAdvisor signs Pfizer, the world’s largest research-based pharmaceutical company to deliver a patient engagement program (PEP) on its platform
  • Pfizer will use the MedAdvisor platform to deliver information and advice to patients to enhance and promote the safe and effective use of its medication
  • Pfizer develops, manufactures and distributes hundreds of prescription medicines, vaccines and over-the-counter products
  • Agreement with Pfizer and renewed programs provide strong validation of the value the PEPs are delivering pharmaceutical manufacturers and the Company’s ability to grow this revenue stream

MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that it has entered into an agreement with Pfizer Australia Pty Limited (Pfizer) to provide a Patient Engagement Program (PEP) for one of its leading medications.

MedAdvisor will work with Pfizer to deliver important information and guidance to patients prescribed with this Pfizer medication. Preparation for the program has already commenced and it will run for an initial period of 18 months.

To view the full announcement, please click on the button below.

Proteomics Share Purchase Plan Offer Document

7th December 2016 – ASX Announcement 

Proteomics International Laboratories Ltd (ASX:PIQ) (the Company, PILL) is pleased to present to you the opportunity to apply to increase your investment in the Company through an offer of shares under the Company’s Share Purchase Plan (SPP).

As announced on 2 December 2016, the Company has successfully completed an oversubscribed placement raising $1.44 million at $0.24 per share to existing and new sophisticated investors. PILL also announced an SPP for existing shareholders to raise up to $480,000.

The SPP is offered exclusively to all eligible shareholders who have an address in Australia or New Zealand and who were recorded on the Company register at 5:00 pm (AWST) on 1 December 2016 (Eligible Shareholders). The SPP provides Eligible Shareholders with an opportunity to buy a parcel of new shares in the Company with no brokerage or commission costs, irrespective of the size of their shareholding, up to a maximum value of $15,000.

To view the full announcement, please click on the button below.

If you would like to receive more information about Proteomics, please click on the button below.

YPB Protects New Mamacare Export Range

7th December 2016, ASX Announcement

  • YPB protects exports of nutritional milk formula
  • Growing uptake by Australian exporters of YPB’s products continues

Brand Protection and Customer Engagement solutions company YPB Group Limited (ASX: YPB) has commenced supply of YPB’s invisible tracer to MamaCare, a leading brand of premium pregnancy products including nutritional milk formula supplements and other well-being products for expectant and nursing mothers.

Mamacare will initially use YPB’s invisible tracer technology to Protect its export products, particularly the newly released export range of nutritional milk formula for pregnant women, as it experiences rapid growth distributing into Pan Asian markets.

To view the full announcement, please click on the button below.

Mobotech Investor Update November 2016

7th December 2016

Following on from last month. We met with the PepsiCo 6 Sigma team in South Carolina last week to formulate and agree the Mobot project success criteria. It was great to be included in the team to ensure deliverable expectations. These should be signed off before Xmas and over the next 6 weeks Magline will be making the necessary end effector changes to meet the agreed criteria. We expect to go to next step trials by early Feb.

Met up again with BBUSA (Bread) last week while in South Carolina. They wish to begin trials with the Mobot again, after 18 months silence. We have scheduled these for end Jan at one of their large Distribution Centres in Florida. We also had a demo of the Mobot with BMW USA. They found us searching youtube, for their need of the ‘world’s smallest forklift’. Mobot is small enough and they have scheduled a trial for late Jan.

Magline continue to support the short-term funding of the Mobots’ market awareness campaign but are awaiting sales developments before they will commit to too much more.

Leaf Resources and Novozymes Launch Biomass-To-Sugars Collaboration

7th December 2016, ASX Announcement 

Leaf Resources’ patented biomass pretreatment process- GLYCELL – is an innovative, high-yield route to clean, economical cellulosic sugars

Leaf Resources today announced a collaboration with Novozymes, the world’s largest producer of industrial enzymes, to further increase the yields and efficiency associated with Leaf Resources’ innovative biomass conversion technology.

GLYCELL1 is a unique combination of well-established process engineering and advanced chemistry. The GLYCELL technology operates at low temperature and pressure, and uses crude glycerin as a low cost, recyclable reagent. The process efficiently deconstructs plant biomass and produces a high-yield of high-quality, concentrated cellulose and hemicellulose sugars, which in turn enables cost competitive production of renewable chemicals.

To view the full announcement, please click on the button below.

E Agri CEO Interview

E Agri Singapore is an Agri-Technology, Private Company that is implementing an innovative technology-driven modular hydroponic growing system. E Agri Singapore is refining a global go-to-market strategy that will be tailored to the characteristics of each country. China for example seeks clean, safe produce and scalable volumes. Whereas more mature markets such as Australia and America seek productivity savings and year-round reliable supply to consumers.

E Agri Singapore is raising capital of US$2.25m to invest in the installation of two facilities in Australia and China, prior to a full market launch and roll out in the second half of 2017.

Please listen to Mr Patrick Duffy, Chief Executive Officer of  E Agri below.

Actinogen Medical Present Xanamem Research at CTAD

6th December 2016, ASX Announcement

Actinogen Medical Limited (ASX:ACW) is pleased to announce the presentation of the latest Xanamem™ research data at CTAD (Clinical Trials in Alzheimer’s Disease) in San Diego. The paper: Xanamem™: an 11ß-HSD1 Inhibitor in current development for the management of Alzheimer’s disease (AD), will be presented by Prof Craig Ritchie on Friday the 9th December.

CTAD is one of the most prestigious international Alzheimer’s congresses, where the latest ground-breaking research into Alzheimer’s disease is showcased. CTAD focuses on promising new Alzheimer’s drugs under development. This presentation follows on from the very successful presentations of Xanamem™ at AAIC (Alzheimer’s Association International Congress) in Toronto, ICE (the International Congress of Endocrinology) in Beijing and Mastering Medicinal Chemistry in Lisbon, over the past few months.

To view the full announcement, please click on the button below.

Meme Australian Share Fund November 2016 Factsheet & Performance Review

Investment Objective: To outperform the S&P/ASX All Ordinaries Accumulation Index over rolling three year periods, through active investment in ASX listed securities outside the S&P/ASX 20.

Investment Approach: The Fund takes an evidence-based quantitative approach to investing and uses a robust and back-tested trend-following strategy to identify investment opportunities expected to provide both positive price appreciation and relative price outperformance over the medium to long term. The Fund rigorously applies a set of capital management rules to manage both risk and return such that any losses are taken while they are small while gains are given room to compound until their long-term price trends become exhausted or their relative out-performance becomes impaired.

To view the full Fund Factsheet and Performance Review, please click on the button below.

To view the Market Analysis, please click on the button below.

Marketboomer Gains Backing of MYOB Founder Craig Winkler

Marketboomer has recently secured investment from one of Australia’s most successful technology entrepreneurs an investors, Craig Winkler.

Craig founded accounting software company MYOB in 1991 and is  a cornerstone shareholder in leading cloud based accounting platform Xero. He is also listed on the 2016 BRW Richlist.

Gaining the backing of an investor of this calibre is testament to the exciting potential of the Marketboomer business.

Following on from Craigs investment, Marketboomer is currently undertaking a ‘top-up’ capital raising round of $1m.

The raise represents a limited opportunity for investors to own shares in a unique, recurring revenue generating business that is poised for a period of rapid growth.

To view the full announcement, please click here.

To Receive Offer, please click on the button below.

miiGroup December 2016 Capital Raise

As you may know, this year has been quite an exciting time for miiGroup, after consolidating the company and focusing our efforts on completing trials throughout 2016.

2017 is shaping up to be an even more exciting year, as we prepare to grow and scale our offering to our ever-growing audience

A quick recap on the growth of our numbers…

MiningLink – 500,000+ monthly visitors
miiFile – 19,500+ Profiles
iComplii - 8,600 verifiedUsers

As we plan for a more robust future, and as part of our restructuring, miiGroup has added a strong advisory board and working towards appointing Brad Birchall and Raz Chorev as Company Directors in January.

With a strong team, fantastic products and growing interest, we are opening a small capital raise to support 2017 growth, and make sure we are not only coping with the growing demand, but also scaling to facilitate our aggressive expansion targets.

For your consideration are the following document links…

Australia’s 4Dx Making Waves In Respiratory Healthcare

2nd December 2016

Australian medtech startup 4Dx is making a bold foray into the global respiratory diagnostics marketplace after strong support from the U.S, U.K and Australian investment community.  Their $4M Series A investment round is set to close, oversubscribed, on December 9th after the inking of deals with major U.S hospitals and expanding relationships with key U.K medical institutions.

4Dx has developed unique software that generates moving, ultra-high-resolution images of motion and airflow in lung tissue.

This revolutionary technology enables clinicians to view and measure abnormal lung function at the earliest stages of disease in a way that has not previously been possible. 4Dx technology is non-invasive and will have a major impact on the way medical professionals are able to diagnose and treat patients with diseases of the lung.

4Dx has also established formal clinical partnerships with several of the biggest and most advanced hospitals in the US, including Cedars-Sinai, The Cleveland Clinic, Children’s Hospital Los Angeles, and the University of North Carolina at Chapel Hill.

The company has also announced the appointment of Dr Bob Figlin to the 4Dx board from December 1st.  Dr Figlin is Deputy Director of the Integrated Oncology Service Line, and Deputy Director at the Samuel Oschin Comprehensive Cancer Institute, part of the world-renowned Cedars-Sinai Medical Center in Los Angeles. He is also Director of the Hematology Oncology Division at the institute.

Dr Figlin says, “4Dx has developed some of the most promising and exciting technology I’ve ever seen in the fight against disease. It will be a privilege to be able to use my medical and business experience to assist the company through this phase of its growth.” Dr Figlin previously co-founded biotechnology company Agensys, which later sold as part of a nine-figure deal.

4Dx founder and chair Andreas Fouras, says, “Dr Figlin brings unparalleled experience and expertise in cancer therapies to 4Dx, where enhanced cancer treatment is among our first priorities. He also brings a vast medical knowledge and adds enormous capacity to our board’s business decision making capacity.”

4Dx is using investment monies to finance further clinical studies in addition to its first FDA submission, expected in Q1 2017. The $4M series A is open for investment in Australia and has also received strong interest from U.S and U.K markets, and will close on the 19th December. The company anticipates the raise will be over-subscribed. An additional round of fundraising is also planned for Q1 2017.

Catcha Group Partner Bulletin December 2016

With the year wrapping up, Catcha Group’s tremendous achievements of 2016:
  • iflix has become one of the fastest growing Internet companies in the region
  • Frontier Digital Ventures made their debut on the ASX (our fifth IPO!) and is making waves globally
  • iCar Asia raised new capital, appointed a new CEO to position itself for its next stage of growth
  • REV Asia is growing in strength, dominating the Malay and Chinese market in Malaysia
  • Wild Digital 2016 was an amazing event, with phenomenal growth in attendees (including the Malaysian PM)

PATRICK GROVE ON ENTREPRENEURSHIP

TODAY

Patrick Grove, 41, has been an entrepreneur for most of his working life, long before calling oneself an entrepreneur became fashionable.

Read more

SHAUN DI GREGORIO ON INVESTING IN FRONTIER MARKETS

CNBC

Shaun Di Gregorio, CEO at Frontier Digital Ventures, talks about investing in the online classifieds space in frontier markets

Watch here

 

Proteomics Completes $1.44 million Placement and Offers SPP

2nd December 2016, ASX Announcement

Medtech company Proteomics International Laboratories Ltd (PILL, ASX: PIQ) is pleased to announce it has completed the first phase of a targeted capital raising by placement of 6m shares at $0.24 to raise $1.44m (the “Placement”).

  • Oversubscribed Placement raised $1.44 million with support from existing and new sophisticated investors
  • Share Purchase Plan to raise a further $480,000
  • Funds to be used to accelerate commercialisation of breakthrough test, PromarkerD, and the rollout of new analytical testing services for the fast-growing clinical trials market
  • Directors to participate in the SPP

The Placement received strong support from existing and new sophisticated investors and was significantly over-subscribed. The Placement was priced at $0.24 per share, a discount of 12.7% to the last sale price and the 20 day VWAP, and includes one for four attaching options. PILL also announces a Share Purchase Plan (SPP) to existing shareholders to raise $480,000 at $0.24 per share. K S Capital Pty Ltd acted as Lead Manager to the Placement.

To view the full announcement, please click on the button below.

Altech Submits Mining Proposal and Mine Closure Plan

2nd December 2016, ASX Announcement

Highlights

  • Meckering mining proposal and mine closure plan submitted to DMP
  • Proposed mining activity is a simple quarry style operation, no drill and blast required
  • Two month mining campaign first 3 years kaolin feedstock
  • Year-round kaolin container loading operation at Meckering site
  • Containers shipped to HPA plant in Johor via port of Fremantle, Western Australia

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to advise that further to its 20 May 2016 announcement of the grant of mining lease M70/1334 at Meckering, Western Australia the Company has now submitted a mining proposal (MP) and mine closure plan (MCP) to the Department of Mines and Petroleum (DMP). The submission marks the next stage of development of the Company’s proposed Meckering kaolin mine, which will provide feedstock for its proposed Malaysian high purity alumina (HPA) plant.

To view the full announcement, please click on the button below.

Actinogen Medical Annual General Meeting & Presentation

30th November 2016, ASX Announcement

Progress with the development of Xanamem

Since addressing you at the AGM this time last year, Actinogen has made substantial progress towards the initiation of XanADu, our Phase II study of Xanamem in mild Alzheimer’s disease. While we did expect to have initiated patient’s recruitment onto the trial by now, as previously announced, ongoing interaction with the FDA in America has led to some changes in the trial design, that required harmonising the protocol globally. We are particularly pleased with the progress we have made in recent correspondence with the FDA and have every expectation we will receive FDA approval in the near future, and to be able to start dosing patients into the study early in the new year. The trial will take around 2 years to complete, so we can expect top-line results by early 2019.

To view the full announcement, please click on the button below.

To view the full Presentation, please click on the button below.

3D Printer Play Aurora Labs Soars to New Heights

30th November 2016, Yahoo News by Stuart McKinnon

Aurora said it was working on a non-binding terms sheet with the company but the details remained “commercial-in-confidence” and the proposal remained incomplete.

The company said it had been in discussions with several of Australia’s biggest mining and resources companies concerning the supply of 3D metal printers to enable them to print spare parts at their mine sites or in a centralised 3D printing facility.

Aurora is looking to team up with a bigger partner with the resources, networks and specialised engineering and technical know-how to market its products to resources companies on a large scale.

To view the full announcement, please click on the button below.

TFS Corporation Overview of Quarterly Results

30th November 2016, ASX Announcement

Q1 highlights

  • Cash EBITDA1 of $0.6m, in line with usual seasonality of operating results
  • Reaffirmation of FY17 guidance for Cash EBITDA to increase by > 25% on FY16
  • Completion of third annual harvest, with yield of 310 tonnes in line with expectations Product sales set for strong growth from Q2, with $39m in inventory at the end of Q1, all forward sold
  • Successful acquisition of grower-owned wood at tender, which will supply multi-year contracts with leading global essential oil company and wood buyers in China
  • Commencement of sales to new wood and oil customers in China and US
  • NPAT of $-7.2m, driven by unrealised FX movements on the biological assets and expensing of one-off costs from the successful bond refinance
  • Strong balance sheet with cash of $107m with significant operating cash generation expected in FY17

To view the full announcement, please click on the button below.

Peppermint Innovation AGM Investor Presentation 2016

29th November 2016, ASX Announcement

Company Snapshot

ASX Fintech company targeting the global mobile payments sector, listed December 2015

Recently recognised by Forbes Philippines as one of Top 24 Fintech start-ups

What we do;

  • Operate an established and commercially deployed mobile banking and payments platform in the Philippines
  • Deliver a unique mobile payment and remittance solution developed specifically for non-bank agent networks.
  • Provide an innovative mobile technology solution to facilitate financial inclusion and consumer convenience

To view the full Presentation, please click on the button below.

Alcidion Chairman’s Letter 2016, Presentation & Appointment of Secretary

29th November 2016, ASX Announcement

Alcidion Group Limited (Alcidion or Company) is pleased to present its Annual Report for the financial year ended 30 June 2016 (FY16 or Period).

Alcidion is focussed on anticipating the needs of the health care industry and we are focused on accelerating the commercialization of our innovative technologies that help create a healthier tomorrow, today.

Our mission remains to help our clients achieve, and sustain, high performance hospital services – by utilising our intelligent software to transform and improve patient care, staff productivity and service performance.

The core of Alcidion’s business model is to create intellectual property in the form of Clinical Decision Support software (CDSS) to improve the quality of care for all patients and improve the productivity of clinicians and care teams.

To view the full announcement, please click on the button below.

To view the presentation, please click on the button below.

To view the Appointment of Secretary, please click on the button below.

Altech Chemicals to Benefit from Growing Global HPA Demand

23rd November 2016, Proactive Investors

Altech Chemicals Ltd (ASX:ATC) has commissioned a market research report for global high purity alumina (HPA) demand to support project debt funding for the proposed plant in Malaysia.

The report noted that global HPA demand grew 19.5% in 2015 compared with 2014 and demand is forecast to remain strong, growing at 16.7% annually through to 2024.

Altech is aiming to become one of the world’s leading suppliers of 99.99% HPA through construction and operation of the proposed HPA plant in Malaysia.

The plan is for the HPA plant to process raw kaolin mined and shipped from the company’s 100% owned Meckering kaolin deposit located in Western Australia.

Iggy Tan, managing director, commented:

“This latest HPA market analysis report confirms the robust outlook for global HPA demand and the HPA pricing assumption used in the financial model for the company’s proposed Malaysian HPA project.”

To view the full announcement, please click on the button below.

Melbourne Security Reseller Tesserent Stealthily Builds US, UK Empire

29th November 2016, CRN By Samira Sarrraf

Melbourne-based network security provider Tesserent is quietly building a security empire that stretches all the way from Australia to and the UK and the US.

Tesserent has been on a growth tear since it went public on the ASX in February 2016. It was understood to be the first such cybersecurity firm to IPO in Australia and its vendor partners include Cisco’s Sourcefire and Kaspersky.

The company acquired 150 education-focused customers and the intellectual property assets of Victoria-based software company Blue Reef in May for $1 million cash and $2.5 million in shares. Tesserent then offloaded the IP six months later for $3.5 million in cash and $300,000 in shares, and kept the customers.

To view the full announcement, please click on the button below.

MedAdvisor Partners with Asthma Australia

29th November 2016, ASX Announcement

  •  MedAdvisor partners with Asthma Australia, Australia’s peak body supporting people with asthma and their carers
  • Partnership aims to improve health outcomes for the estimated 2.4 million (1 in 10) Australians living with asthma, via the MedAdvisor platform
  • High priority health cost reduction area: total cost of asthma in Australia is estimated to be $28 billion per annum with $1.1 billion directly related to productivity costs
  • Further builds on MedAdvisor’s health association partnerships that play a key role in driving patient awareness of MedAdvisor
  • In line with the Company’s strategy to enhance health outcomes for the 11m Australians living with chronic conditions and lower costs associated with poor medication adherence

MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce it has entered into a partnership with not-for-profit health association Asthma Australia. The partnership will run for an initial period of 12 months.

To view the full announcement, please click on the button below.

Jetpack Aviation in $1.9m Raising

28th November 2016, The Australian By Mitchell Bingemann

Jetpack Aviation is offering 2 per cent of its company to raise about $1.9 million as the company completes designs of its $US250,000 device before it goes on sale to private buyers early next year.

The company’s test pilot and chief executive David Mayman — one of the Australian founders of local business directory true­local.com.au — said the funds would be used to complete production of its twin-engined jetpack, the JB-10, and start development of a new electric-powered jetpack.

“Investment in this company is not just about the opportunity of selling our current jetpacks. It’s about the future of electric commuter vehicles, which is an extraordinary field that will explode very quickly,” Mr Mayman told The Australian.

Prominent Oncologist & Researcher Joins 4Dx Board

November 30, 2016

Australian technology start-up 4DX has attracted one of the biggest names in global oncology as its latest Board member.

Robert A. Figlin, MD, FACP, joins the 4Dx board on December 1st.  Dr Figlin is Deputy Director of the Integrated Oncology Service Line. He also serves as the Deputy Director at the Samuel Oschin Comprehensive Cancer Institute, part of the world-renowned Cedars-Sinai Medical Center in Los Angeles and is Director of the Hematology Oncology Division at the institute, where he is in charge of integrating research and clinical strategies across all the Cedars-Sinai campuses.

Since his arrival at Cedars- Sinai six years ago, he has established the Experimental Therapeutics Program and successfully recruited clinical research staff in critical specialty areas such as breast cancer, bone marrow transplant, gastrointestinal oncology, genitourinary oncology, survivorship, and cancer biology.

Dr Figlin says, “4Dx has developed some of the most promising and exciting technology I’ve ever seen in the fight against disease. It will be a privilege to be able to use my medical and business experience to assist the company through this phase of its growth.”

Dr Figlin co-founded Agensys – an early stage biotechnology company focussed on developing novel therapies for cancer.  The company has since been sold to Astellas Pharmaceuticals as part of a nine-figure deal.

4Dx founder and chair, Andreas Fouras, says, “Bob Figlin brings unparalleled experience and expertise in cancer therapies to 4Dx, where enhanced cancer treatment is among our first priorities. “Bob brings a vast medical knowledge and adds enormous capacity to our board’s business decision making capacity.”

Lung cancer is the biggest killer of all cancers and the current standard treatments of chemotherapy and radiotherapy have devastating effects on the lungs. 4Dx technology is non-invasive and will positively impact the way medical professionals are able to diagnose, and treat their patients.

“4Dx is undergoing significant acceleration and is thrilled to have a clinician, researcher and entrepreneurial thinker in Bob Figlan join our team.”

“This revolutionary technology and the development of unique software to generate moving, ultra-high-resolution images of motion and airflow in lung tissue enables clinicians to view and measure abnormal lung function at the earliest stages of disease in a way that has not been possible before now.”

As well as their association with Cedars- Sinai, 4Dx has also created partnerships with other leading hospitals such as the Cleveland Clinic and the Children’s Hospital Los Angeles in the US, and The Alfred and Peter Mac in Australia.

BPS Technoloy AGM Presentation and CEO address

28th November 2016, ASX Announcement

The Company and its Management has made considerable headway in the twelve months since our last AGM:

  • The Group’s revenue increased to record levels, rising 4% to $50.2 million— breaking the $50 million threshold for the first time
  • Our Gross profit grew by 3% to $38.6 million, driven by development of new and existing Bartercard territories
  •  The Bartercard business introduced a new sales model without joining fee accelerating activity across the Bartercard network, with Australia showing growth in new member sales of 25% year-on-year but this was not without some cost
  • Our Earnings before interest, tax, depreciation and amortisation (EBITDA) of $9.5 million was $0.5 million lower than the previous period as a result of the reduced joining fees to optimise the Bartercard sales model
  • Net profit after tax was $7.34 million, $0.5 million lower than the 2015 result – this tracked the EBITDA outcome
  • Dividends paid to shareholders amounted to 4.0 cents per share comprising a 2.0 cent unfranked interim dividend and a 2.0 cent fully franked final dividend
  • We expect Dividends going forward to be fully franked
  • In December 2015 we raised five million dollars via convertible notes which is set to be repaid or converted on or before December 2016.

To view the full announcement, please click on the button below.

To view the full Presentation, please click on the button below.

The Room Xchange CEO Interview

The Room Xchange is an innovative online accommodation marketplace that connects people with a spare room with guests who are willing to Xchange a couple of hours a day of help around the house in Xchange for food and accommodation.

The Room Xchange is the easiest and securest way for people to use their extra space as a resource and connect with a growing community of like-minded people who want to experience independent living, without the high cost.

Please listen to Ms Ludwina Dautovic, Founder and CEO of The Room Xchange below.

OncoSil Pancreatic Cancer Clinical Study Update

28th November 2016, ASX Announcement

OncoSil Medical Limited (ASX: OSL) (OncoSil Medical or the Company) a medical device company focused on localised treatments for patients with pancreatic and liver cancer, is pleased to provide an update on its global OncoPaC clinical study programme.

Highlights

  • Johns Hopkins Hospital and MD Anderson Cancer Centre are the leading U.S. centres.
  • Investigational Review Board (IRB) process has commenced and is on-going for these two U.S. centres. • Guy’s and St Thomas’ Hospitals, London are the leading UK centres.
  • Monash Health has agreed to be the lead Australian centre – ethics submission filed and under review.

To view the full announcement, please click on the button below.

Alcidion to Present at ASX CEO Sessions

28th November 2016, ASX Announcement

Alcidion Group Limited (ASX:ALC) today announced that it has accepted an invitation to present at The CEO Sessions on Tuesday, 6th December 2016.

The CEO Sessions, presented by the Australian Securities Exchange (ASX) and the Finance News Network (FNN), are a forum for investors. CEOs and senior representatives of listed companies present their investment story and can be joined afterwards for an informal meet and greet session, with lunch provided.

To view the full announcement, please click on the button below.

Aurora Labs: $5m to $60m in Three Months

26th November 2016, The West Australian By Nick Sas

Christmas has come early for David Budge. The founder, chief executive and major shareholder of metal 3-D printing company Aurora Labs has seen the value of his small tech outfit jump 1150 per cent since listing on the Australian Securities Exchange in August.

It is the type of share price movement that small cap companies dream of — and for Mr Budge, it is a big pay day.

The Aurora boss owns 43.5 per cent of the company, taking his personal wealth to $59.9 million yesterday. His holding was worth $4.8 million in August.

Speaking to WestBusiness from the company’s Bibra Lake base, Mr Budge said he was as surprised as anyone.

To view the full announcement, please click on the button below.

ThinCats Partners with DomaCom

As foreshadowed after our recent announcement of a partnership with DomaCom Australia Limited (www.domacom.com.au), this is the first mortgage backed loan listed on our platform offering competitive interest rates on a low LVR property lend.

DomaCom is the Investment Manager of the DomaCom Fund which facilitates fractional property investments via an online platform. DomaCom facilitates the equity component of property purchases and ThinCats Australia facilitates the debt component.

Perpetual Trust Services Limited (the Borrower) is the Responsible Entity of the DomaCom Fund and holds each property on trust for the investors. All loans listed under this arrangement have been mandated by Perpetual to have a maximum LVR of 50%, at least 1x interest coverage based on net earnings from the property and a 2-months interest buffer.

Further information: Please visit www.thincats.com.au. Membership Agreement is available under the ‘Resources’ tab.

Folkestone’s Investor Update – Have A-REIT Prices Bottomed & Construction Forecasts – Whats Ahead?

Have A-REIT Prices Bottomed Out?

Record low bond yields have supported the valuations and profitability of Australian real estate investment trusts (A-REITs) over the past few years and A-REIT’s have outperformed equities in 2014 & 2015.

The recent bond market sell-off has impacted on A-REIT prices. The question investors need to ask is whether the rapid rise in bonds will continue and A-REIT prices fall further, or has the pendulum swung to far, too quickly?

Read more

Construction Industry Forecasts – Whats’s Ahead?

For the 1.1 million Australians who work in the building and construction industry and the 24 million Australians who live, work and play in the built environment, the $200 billion construction sector is the backbone of the economy.

Here are eight key findings from the most recent Australian Construction Industry Forum (ACIF) Construction Forecasting Council’s Australian Construction Market Report, November 2016.

Read more

The Coming Global Shortage of Phosphorus and How You Can Invest In It

25th November 2016, Dollars and Sense By Shashi Kumar

The 15th element of the Periodic Table, Phosphorus, is unlike other commodities such as oil, gold and silver. It is a non-renewable commodity with limited supply in the world. It’s a wonder that the element doesn’t get the limelight it deserves despite being essential for all living things.  With some researchers estimating the production of Phosphorus to hit maximum level as soon as 2035 and for all Earth’s reserves to be depleted in as soon as 50-100 years, should you be worrying about an impending great Phosphorus shortage?

To view the full announcement, please click on the button below.

 

Moelis Initiates Research On BPS

25th november 2016, ASX Announcement

BPS Technology Limited “BPS (ASX:BPS) is pleased to announce that Moelis & Company, a leading USA and Australian Investment Bank and Stock Broker for the Mid-Cap sector, has initiated research on BPS with a favourable recommendation.

About BPS Technology Limited (ASX: BPS)

BPS Technology Limited (ASX: BPS) provides technology and payment platforms centred on SME’s. It is a profitable business operates in eight countries, capitalising on a number of significant growth opportunities. BPS operates three highly complementary and scalable businesses – Bartercard, bucqi and TESS.

Bartercard operates the world’s largest trade exchange. It allows SME’s to conduct $600m of additional business without the use of cash. bucqi is a disruptive payment, loyalty & rewards platform that allows consumers to pay merchants via an app for goods and services without using a card or cash. TESS develops software for trade exchanges.  It is recognised and recommended as the preferred software by the global governing body of the industry.

To view the full announcement, please click on the button below.

Altech Chemicals Secures Johor HPA Site

25th November 2016, ASX Announcement

Highlights

  • Lease signing ceremony secures HPA site at Johor
  • 20-year lease agreement, with 20-year renewal option
  • Johor is the ideal location for HPA production and distribution

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to advise the attendance of managing director Iggy Tan at the Johor Corporation official lease signing ceremony. The lease is for the land Altech has secured at the Tanjung Langsat Industrial Complex, Johor, Malaysia as the site of its proposed high purity alumina (HPA) plant.

The Company executed a 20-year lease agreement, which includes a 20-year renewal option, with TPM Technopark Sdn Bhd, a wholly-owned subsidiary of Johor Corporation.

To view the full announcement, please click on the button below.

gridComm CEO Interview

gridComm is an Internet of Things (IoT) technology company that transforms a city’s power grid into a network that can communicate with every streetlight – a smart grid. The gridComm solution technology comprising proprietary semiconductors, network software and a SaaS analytics platform enables the monitoring of streetlight infrastructure in real time, thereby reducing a city’s annual electricity by as much as 50%.

The technology is increasingly validated as companies such as Downer, Intel, IBM and Philips seek partnering agreements for deployment globally.

Please listen to Mr Mike Holt, CEO of gridComm below.

Ballr CEO Interview

Ballr is a free gaming platform for fans to connect, compete and communicate during real-time sporting events.

It is going to transform the way fans consume live sport, and create a multi billion dollar platform for brands to reach new customers.

Ballr have exclusive partnerships with English Premier League clubs including Manchester United and Manchester City. Ballr have offices in Singapore, Sydney and Delhi.

Please listen to Mr Sam Jones, Founder & CEO of Ballr below.

Aeeris Updated Business Profile and Chairman’s Address to Shareholders

24th November 2016, ASX Announcement

The past year and a half has seen significant progress for your Company Aeeris.

Much energy has been focused on the development and advancement of the holding company’s sole operating subsidiary Early Warning Network Pty Limited (EWN), following the IPO in April 2015.

The EWN business has progressed in so many areas since the IPO. We have:

  • assembled an excellent team;
  • progressed technical development of products, services, and customer offerings;
  • undertaken a deep R&D effort, with significant new technologies created;
  • implemented an effective sales strategy, winning new customers and future pipeline;
  • refined our market positioning, pricing, strategy; and
  • defined a clear strategy for the future, and our financial objectives.

To view the full announcement, please click on the button below.

To view the Business Profile, please click on the button below.

Analytica Chairman’s Address, Annual General Meeting & Presentation

24th November 2016, ASX Announcement

Over the last 12 months the Analytica team has worked tirelessly to put us closer to a position to enable execution of a global licence deal for both the PeriCoach and the ASB.

As stated at the last AGM Analytica’s strategy to commercialize the PeriCoach and the ASB was to partner with multinational medical device companies. We see ourselves as an R & D company, not a marketing company.

After talking to multinational medical device companies, US based Investment Bankers and external consultants we soon realised that Analytica needed to do several things in order to get the best possible deal on our terms.

To view the full announcement, please click on the button below.

To view the full Presentation, please click on the button below.

Alcidion to Present at Wilsons Healthcare IT Conference

15th November 2016, ASX announcement

Alcidion Group Limited (ASX:ALC) today announced that it will present at the Wilsons Healthcare IT Conference on Wednesday, 30th November 2016.

The goal of the conference is to educate investors about how technology can increase the efficiency of healthcare spending and improve health outcomes for patients.

Alcidion is honoured to be one of six companies invited to speak. Executive Director, Mr. Nathan Buzza will present on behalf of Alcidion at 9.15am.

The event will be attended by approximately 40 institutional investors who are new to healthcare IT and e-health investment opportunities and looking to gain a more in-depth understanding.

To view the full announcement, please click on the button below.

Crowd Mobile Investor Presentation November 2016

23rd November 2016, ASX Announcement

Crowd Mobile | A Mobile First Company
Mobile Payments underpin Q&A and Mobile Content Subscription divisions

Question & Answer (Q&A)
Crowd Mobile develops engaging mobile products seamlessly connecting those seeking answers with experts qualified to give them

Mobile Payments
Both divisions are underpinned by a seamless m-payment process through Crowd Mobile’s Telco partners/Apple/Google. Faster and more convenient than credit cards for users

Mobile Content Subscription
Crowd Mobile delivers mobile content – games, mobile security, applications, education, apps, music & video to millions of consumers across the world

To view the full Presentation, please click on the button below.

Altech has Robust Outlook for Global HPA as Demand is Confirmed

23rd November 2016, ASX Announcement

Highlights

  • Global HPA demand increased by 19.5% in 2015
  • Annual HPA demand forecast of 86,831tpa by 2024 (est. 2016: 25,315tpa)
  • Altech’s strategy of focusing on 4N HPA endorsed
  • HPA use in lithium-ion batteries offers incremental demand
  • Current reported HPA price in Japan is ~US$30,000/t
  • Threat of substitutes for HPA remains low

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to provide an update on the outlook for global high purity alumina (HPA) demand from a report entitled “High Purity Alumina Market – Global Industry Analysis and Forecast, 2016 – 2024” by Persistence Market Research (“Persistence”), commissioned as part of the current project debt funding due diligence program.

To view the full announcement, please click on the button below.

ISG Financial Services Property Offering Forecasts 25.52% Return

Location:  Brisbane North property hotspot 23KM North from Brisbane CBD
Property: 60 Lot Land Subdivision
Forecast Return to Investors: 25.52%* (total, net of fees), December investment.
Forecast Return Horizon: Forecast completion October 2017* (11 months from December 2016)
Minimum Investment: $100,000 AUD
Total Amount To Be Raised: $5.25M

Investment Structure: Australian Pty Ltd Company. Investors obtain redeemable preference shares. The offer is a private offer, made directly to Sophisticated, Professional and Experienced investors via an Information Memorandum.

Developer Profile:  Multi award winning Queensland property developer with over 15 years of experience in residential and commercial property projects. Have delivered over $800 Million in total project value.

*Please note: Does not constitute an information memorandum or formal offer document. Figures presented are forecast figures only. The forecast financial information has been prepared on the basis of numerous assumptions which are set out in Section 10.8  Forecast Feasibility Information – Assumptions, in the offer document.

About ISG:

  • ISG Financial Services Limited holds Australian Financial Services Licence No. 290328 on behalf of the ISG Group (ISG)(1).
  • Specialised fund manager
  • Historically returned investors 20%+ per annum (2)
  • Investment time horizons usually between 12 and 28 months
  • The group directors and executives have over 50 years of experience in investment management, funds management, investment banking, and capital raising.
  • Group executive experience with over $4.3 billion in property funding, and have managed funds in excess of $1.3 billion.
  • Over $179 million in total project value.

(1) Though ISG is licensed by the Australian Securities and Investment Commission (ASIC), readers should be aware that ASIC neither endorses, supports nor approves of any information, claims or services provided by ISG and/or its agents or representatives.

(2) Returns are not guaranteed. Past performance does not guarantee future performance.

4Dx to Close Capital Raise

4Dx Limited is pleased to announce that due to an overwhelming response, as of 5pm AEDT, Friday, 9 December, 2016, the Company’s $4m Series A capital round will be officially closed.  It is anticipated that the round will close oversubscribed.

4Dx is extremely pleased with the response to our capital raise with the domestic investment community demonstrating a deep understanding of our proposition, and the value inherent in it.

This result indicates a very clear acceptance of the need for 21st century diagnostic technology in the medical marketplace.  The enthusiastic reception 4Dx has received delivers 4Dx a broad base of investors and makes us highly optimistic about the prospects of a second round of capital raising in early 2017.

Funds from the Series A investment round will be used to take the company’s first software product to market, including clinical studies to further validate the product and the entire 4DXV technology platform.  Funds will also be used for the development and submission of its first application for U.S. Food and Drug Administration (FDA) clearance.

Major news media has picked up on the terrific progress being made by 4Dx, including an article published in The Australian newspaper’s Business Review section on 14 November 2016, and an article published in the Australian Financial Review on 21 November 2016.

Punakaiki Fund Has Another Stab at Raising Money From Retail Investors

2nd November 2016, NBR By Fiona Rotherham

The Punakaiki Fund, which makes long-term investments in high-growth New Zealand companies, has launched fundraising offers at $19 per share in New Zealand and Australia with no set amount being targeted.

The New Zealand offer due to open on Nov. 9 is a public one open to anyone through a product disclosure statement (PDS) approved by the market regulator while the Australian one opens today and is to wholesale investors only.

Both offers close at the end of the month and are on the same terms apart from the New Zealand one having a minimum investment of $1,900 compared to a minimum $56,000 in Australia. It’s the first time the fund has attempted to raise money across the Tasman.

To view the full article, please click on the button below.

To receive the offer, please click on the button below.

Punakaiki Fund Now Open

Punakaiki Fund is pleased to announce that its offer to sophisticated Australian investors is now open.

Punakaiki Fund is New Zealand’s premier investor in high growth companies, with NZ$20 million of assets across 18 investments including Vend, Timely, Raygun, Vibe Communications, Onceit, Melon Health and EverEdge. Our 18 investments have combined annualised quarterly revenues of $69 million and almost all of the companies do not need to raise capital again to be sustainable.

Punakaiki Fund has access to the best investment opportunities in New Zealand’s strong growth-company ecosystem and intends to IPO within the next 24 to 30 months.

The Xchange Economy Business That Has Your Safety and Security at its Core

We understand that safety and security are a very important part of any Xchange and that is why the partnership with CVCheck will help towards ensuring the best experience for our Hosts and Guests. Following is an example of the wonderful benefits of an Xchange and how the CVCheck partnership can give you peace of mind.

Ludwina, Founder and CEO of The Room Xchange’s adult daughter was at a music festival where she met a friend, Guillaume. He was travelling around Australia on a Working Holiday from Canada. Guillaume kindly gave her daughter a ride home from the festival.

Ludwina’s daughter and Guillaume then decided they wanted to spend some time together back in Melbourne. Guillaume said he was happy to sleep in his van. Ludwina naturally said: ‘No, no, no… you can’t sleep in your van; please have our guest room.’

To view the full article, please click on the button below.

US Residential Fund Investor Update November 2016

21st November 2016, ASX Announcement

About the Fund

  • Yield play on the strengthening US residential rental market
  • Currently own 122 houses in Texas, Georgia, Ohio, with Patriots Pointe multifamily apartment complex in North Carolina under contract
  • Significant growth potential in yield and narrowing of current NTA discount of 49.3%
  • Listed on ASX on February 2015

Strategy

Targeting returns from the following areas:

  • Strategic shift to focus on higher returning US multifamily properties
  • Redeployment of capital into multifamily apartment complexes where single family properties value is realised
  • Enhancing operations through management restructuring including reduced directors and internalisation of the management

Corporate Overview

  • Portfolio valued at AUD 22m, with market capitalisation at AUD 8.0m

To view the full announcement, please click on the button below.

‘Next Cochlear’ 4Dx Closes Capital Raise as FDA Approval Enters Sight

21st November 2016, AFR Yolanda Redrup

Medical imaging startup 4Dx has raised $2.5 million from a range of retail and high net worth investors, which the business will invest in its clinical trials that will see the company approved by the US Food and Drug Administration by mid next year.

The company, which already has one major deal with Los Angeles hospital Cedars Sinai to use its lung imaging technology, also has an additional $2.5 million committed that is expected to close this week, taking its total series A raise to more than $5 million.

Chief executive Andreas Fouras said the company had developed a strong investor base featuring healthcare professionals and business bigwigs from retail, resources and banking and finance, making him confident the company could go achieve its ambitions of being as successful as Cochlear.

“These investors are just dipping their toes in the water at the moment with us, so that makes me excited about what it means for their ability to take a stronger position going forward when we release strong results next year,” he said.

To view the full announcement, please click on the button below.

YPB Signs Master Supply Agreement With Blackmores

21st November 2016, ASX Announcement

  • YPB to provide its full range of products and services to Blackmores under two year agreement
  • The momentum in YPB’s IP commercialisation plan is building

Brand Protection and Customer Engagement solutions company YPB Group Limited (ASX: YPB) has signed a two-year Master Supply Agreement (MSA) with Blackmores Limited (ASX: BKL) under which YPB’s suite of Brand Protection and Customer Engagement solutions can be deployed across the Blackmores range. The MSA sets the framework for the supply of YPB products and services to Blackmores.

YPB’s PROTECT solution is a patented, invisible, indestructible, uncopiable tracer or marker which can be seamlessly and easily incorporated into plastics, inks and fibres to create protected, intelligent packaging. The tracer is used to confirm the authenticity of a product in conjunction with YPB’s patented scanner. The intelligent packaging can then be used with YPB’s TRACK AND TRACE solution to DETECT counterfeit goods and ensure supply chain integrity, a major issue for exporters.

To view the full announcement, please click on the button below.

P2P Lender ThinCats Receives Two New Accreditations

18th November 2016, Crowdfund Insider By JD Alois

ThinCats, a P2P lender in secured business loans, has received two new accreditations in recognition of its platform operations. ThinCats has been recognized by the National Association of Commercial Finance Brokers (NACFB) for best practice within commercial finance broking. Simultaneously, Defaqto has given ThinCats a 5-star rating for product quality and comprehensiveness.

ThinCats announced yesterday it had become a patron to the commercial finance broking authority, NACFB and is working with the entity to encourage good practice, education and training within the industry.

To view the full announcement, please click on the button below.

SuperConcepts Partners with DomaCom to Provide SMSF Trustees with Easier Ways to Access Property Investments

18th November 2016, Professional Planner

SuperConcepts has announced a partnership with DomaCom to provide SMSF trustees and their advisers with easier ways to access property investments. The fractional nature of the DomaCom Fund breaks down the high cost of property allowing advisers to achieve specific asset allocation in the sector.

The new development follows a recent analysis of SMSF investment trends by SuperConcepts which showed using SMSFs to buy property continues to be popular.

In announcing this new development James Fitzpatrick, Chief Customer Officer at SuperConcepts, said, “The asset allocation to the property sector remains high at 20.6 per cent of investments for the September 2016 quarter and the addition of the DomaCom Fund will provide an innovative solution for our SMSF clients with an appetite for property investment.”

To view the full announcement, please click on the button below.

YuuZoo Launches YuuTV, A New Video Streaming Platform For Smartphones With Exciting New Features

17th November 2016, BusinessWire

Launch Taps Into New Deal With Relativity Media, One Of The World’s Largest Independent Movie Studios

New platform transcends YuuZoo into a whole new playing level, opening up VOD (entertainment / news and user-generated content) presenting a huge revenue potential in a market that is expected to grow from $33.32 Billion in 2015 to $73.90 billion dollars in 2024. 

Key Highlights:

  • YuuTV connects with users directly, using push notification and allowing them to upload video content directly from their phones onto multiple themed channels
  • YuuTV will become prime new distribution pipe for content
  • YuuZoo’s recently announced agreement with Relativity Media will allow YuuTV to offer 4 billion consumers in the 69 markets covered by YuuZoo’s partners unique premium content in films, TV, sports, fashion and music
  • Yuuzoo’s global payment platform YuuPay will be used for all YuuTV’s online and mobile payments

To view the full article, please click on the button below.

SuperConcepts Partners with DomaCom, Giving Access to 40,000 Funds

18th November 2016, ASX Announcement

SuperConcepts has announced an exclusive partnership with DomaCom (ASX:DCL) to provide SMSF trustees and their advisers with easier ways to access property investments.

SuperConcepts is a leading provider of self-managed superannuation fund (SMSF) administration, software and education services to SMSF trustees, accountants and financial advisers, servicing more than 40,000 funds. SuperConcepts comprises a number of sub-brands including AMP SMSF, Ascend, Cavendish, Multiport, Justsuper, SuperConcepts, Super IQ, superMate, your SMSF and a part ownership of Class Ltd.

The addition of DomaCom follows a recent analysis of SMSF investment trends by SuperConcepts which showed that using SMSFs to buy property continues to be popular.

To view the full announcement, please click on the button below.

Real Estate Investar Ltd Hits 240000 Members

17th November 2016, Proactive Investors

Real Estate Investar Ltd (ASX:REV) is on track to hit its goal of 250,000 members by the end of 2016 after recently hitting the milestone of 240,000 members.

REI is a leading provider of integrated services to Australian and New Zealand property investors to assist in the identification, analysis, acquisition, tracking and accounting of investment property.

Members are a key value driver, they are offered a free set of online tools to analyse investment properties – REI then monetises members through paid subscriptions and other products and services.

Revenue in the September quarter of $1.26 million was 31.5% higher compared with the corresponding 2015 quarter.

To view the full article, please click on the button below.

 

Alcidion TechKnow Investor Roadshow Interview

17th November 2016, ASX Announcement

Alcidion Group Limited (ASX:ALC) today announced that Executive Director, Mr. Nathan Buzza’s interview from the TechKnow Invest Roadshow is available on the Alcidion website.

Mr. Buzza provides a comprehensive overview of Alcidion as an investment opportunity and of the medical technology market as a whole.

The TechKnow event is the premier investor focused technology event in Australasia, attracting over 700 investors interested in being educated about investment opportunities in the technology space. The event visits three major Australian cities for each roadshow. Mr. Buzza presented Alcidion to investors at the event in Melbourne, Sydney and Brisbane in late October 2016.

To view the full announcement, please click on the button below.

AsiaPhos NRA Report: Collaboration with Customer Shows Competitive Advantage

  • Steady share price despite poor results. AsiaPhos reported a net loss of S$0.55m for 3Q16 on revenue of S$9.24m for 3Q16, thus bringing 9M16 net loss to S$1.1m. Rainy weather led mining to cease in late 2Q and resume in late October 2016. Hence, rock production likely fell year-on-year, leading to the poorer than expected results. On the other hand, we are encouraged that AsiaPhos’ share price has remained steady, suggesting that the negative performance has already been priced in. We maintain our Overweight rating on AsiaPhos and retain our forecasts and valuation in this update, pending review when it releases its 4Q16 results.
  • 4Q16 outlook remains weak. The average selling prices of both phosphate rock and P4 fell by 13.6% and 16.8% respectively from 2Q16. Thus, upstream and downstream gross margins retreated to 24.6% (2Q16: 25.2%) and 12.2% (16.5%) in 3Q16. The good news is that operating expenses remain well controlled, with general and administrative costs rising by only 4% year-on-year. P4 production rose by 1,370 tonnes from 2Q16 as the company stepped up both production and marketing activities. However, an industrial accident occurred on 24 October, leading to the temporary cessation of P4 production. While AsiaPhos is selling the phosphate rocks originally reserved for P4 production, we reckon that the company’s 4Q16 outlook may remain weak.
  • Considering more cooperation agreements with other industry participants? In November, AsiaPhos announced that it has signed a MOU with Mianyang Aostar Phosphorus Chemical Industry Co., Ltd, to cooperate by 1) enhancing communication of information with each other in relation to the market for P4 with the aim of establishing reasonable pricing, 2) selling up to 100,000 tonnes of phosphate rocks to the latter in 2017 and 3) explore the purchase of electricity at preferential rates. This MOU is interesting as it will allow AsiaPhos to leverage on its larger neighbour’s resources for mutual benefit. AsiaPhos has a bargaining advantage as Mianyang Aostar purchases phosphate rock from the company. We will not be surprised if AsiaPhos makes more agreements with other industry players.

If you would like to download the full announcement, please click on the link below. 

SUDA Presents Data On Novel Penetration-Enhancing Technology

17th November 2016

SUDA LTD (ASX: SUD), a leader in oro-mucosal drug delivery, today announced that Mr. Stephen Carter, Managing Director and CEO, presented data on the Company’s novel penetration-enhancing technology at the Annual Symposium of Drug Delivery Systems, being held on 16-19 November 2016 in Nanjing, China.

This scientific conference brings together scientists, academia, healthcare providers, policy makers and investors to provide insights into advances in drug delivery technologies. Mr. Carter chaired a session on “Tackling the Barriers in Different Routes of Drug Delivery.”

SUDA recently filed a provisional patent application with IP Australia for its novel mucosal penetration drug delivery technology. Mr. Carter presented data suggesting that the Company’s new technology, based on unique combinations of hydrotropes, can significantly enhance the permeation of active drugs through the oro-mucosal membrane into the blood system.

If you would like to download the full announcement, please click on the link below. 

Proteomics and Linear Partner in Testing and Clinical Trials

15th November 2016, ASX Announcement

Medical technology company Proteomics International Laboratories Ltd (ASX: PIQ) (PILL) and clinical trial specialists Linear Clinical Research Ltd (Linear) are set to offer a combined advanced analytical testing and clinical trial package from January 2017.

  • PILL and Linear sign partnership deal to offer a comprehensive analytical testing and clinical trial package
  • Potential to double PILL’s analytical services revenue and break new ground in companion diagnostics
  • Partnership to target the fast-growing biopharmaceuticals and oncology markets
  • New service to commence January 2017

To view the full announcement, please click on the button below.

Folkestone Enters JV For Hotel Development At Green Square

15th November 2016, ASX Announcement

Folkestone (ASX:FLK) announced today that it had entered into a 50/50 joint venture with Furnished Property to develop a 142 room hotel at Green Square, Sydney.

The site, at 18 O’Riordan Street, Alexandria, is located within the $13 billion, 278 hectare Green Square Urban Regeneration Area (‘GSURA’) and is strategically located approximately 100 metres from the Green Square Train Station. The Sydney Airport Domestic and International Terminals are two and three stops respectively to the south with Central Station, one stop to the north. Green Square is one of the most significant urban transformation programs under construction in Australia, revitalising the industrial edge of Sydney’s inner south into a vibrant global village. Green Square Town Centre, which is the centerpiece of the GSURA, is in close proximity to the proposed hotel.

To view the full announcement, please click on the button below.

TFS Corporation Chairman’s Address 2016 Annual General Meeting & Presentation

11th November 2016, ASX Announcement 

TFS delivered strong progress across the business in 2016 and we either met or exceeded our financial and operational targets, as well as delivered on a number of important strategic initiatives which position the Company well for the coming years.

At a financial level, the Company’s performance met the earnings guidance that was provided at the start of the year. FY2016 Cash EBITDA – which is the best measure of how the business has performed – was $62.2 million, up 8% on FY2015. Cash revenue of $175.5 million was 16% higher than FY2015, with increases across all the Company’s main revenue streams. Net Profit After Tax of $90.1 million was lower than FY2015, however this was due to a reduction in non-cash revenue driven by foreign currency movements. Our cash position at year end was a strong $107 million, putting TFS in a strong position to deliver further growth in FY2017. The Board also elected to maintain a final fully franked dividend of 3 cents per share.

To view the full announcement, please click on the button below.

To view the full Presentation, please click on the button below.

World’s First Real Jetpack Now On Sale

11th November 2016, International Business Times By Mary-Ann Russon

Always wanted to fly? Well, your dream could soon come true as an Australian invention that flew around the Statue of Liberty using a jetpack is now finally available for sale.

In November 2015, David Mayman made international news and set a new record for demonstrating that he was able to use a jet turbine-powered backpack to vertically take off and fly up to a height of 200ft, where he circled the Statue of Liberty on Staten Island.

Jetpack Aviation, co-founded by Mayman and award-winning inventor Nelson Tyler, claims that the jetpack invention is the world’s only “true jetpack” because it looks and functions just like fictional descriptions of the device – a backpack with two turbine engines attached to it that propels the wearer into the air.

The JB-10 JetPack is powered by either diesel or kerosene and requires no licence to fly. In contrast, other jetpack inventions currently being developed require rocket fuel to work, are too big to really be called a jetpack, like the Martin Jetpack “personal jetpack” by New Zealand-based Martin Aircraft Company, which is powered by a V4 200 horsepower petrol engine controlling two ducted fans.

To view the full announcement, please click on the button below.

Proteomics PromarkerD Test Kit Production Deal Signed

11th November 2016, ASX Announcement

Medtech company Proteomics International Laboratories Ltd (PILL, ASX: PIQ) today reached a strategic milestone in its commercialisation pathway for PromarkerD, the company’s predictive test for diabetic kidney disease.

  • PILL signs production contract with Monash Antibody Technologies Facility
  • Custom antibodies will be designed to recognise the diabetic kidney disease ‘fingerprints’
  • Strategic milestone in production of a pathology lab test

The company has signed a contract with the Monash Antibody Technologies Facility to produce the custom antibodies needed for a multiplex ELISA (Enzyme-linked immunosorbent assay), which is the precursor to a pathology lab In vitro Diagnostic (IVD) test.

To view the full announcement, please click on the button below.

iFAST Acquire Insurance Brokerage Firm In Hong Kong

14th November 2016, iFAST Corporation

The Board of Directors of iFAST Corporation Ltd. (“the Company” or together with its subsidiaries, the “Group”) wishes to announce that the Company had entered into an Agreement for the Sale and Purchase of the entire share capital of Canadian Financial Consultants Limited (“Canadian Financial Consultants”), representing 100,000 shares of HK$1.00 each in the issued and paid-up share capital of Canadian Financial Consultants from Ripcord Limited and Befriend Company Limited (“Acquisition”).

Canadian Financial Consultants is principally engaged in insurance brokerage in Hong Kong. It is a member of the Hong Kong Confederation of Insurance Brokers (“CIB”) for the lines of business in General Insurance and Long Term (including linked long term) Insurance. Canadian Financial Consultants is also registered with the Mandatory Provident Fund Authority of Hong Kong (“MPF”) to act as a MPF Principal intermediary.

The Acquisition will allow the Group to conduct insurance brokerage activities in Hong Kong and expand the range of products available on its investment platforms.

To view the full announcement, please click on the button below.

4Dx Features In The Australian

14th November 2016, The Australian By Sarah-Jayne Tasker

A “dream job” studying airflow through jet engines has led to an innovative lung imaging system that Professor Andreas Fouras is convinced will disrupt a $25 billion a year global industry and dramatically change healthcare outcomes.

The Australian father of five, who has relocated his family to Los Angeles to progress his venture, says he has found his opportunity to make a difference.

With his team at 4DX, he has devised a new way of imaging the lungs by showing in real-time motion how air flows through them, pinpointing the areas that aren’t working well and those that are.

Professor Fouras says given the best technology for imaging the lungs is 50 years old, his innovation, which relies on computer software and four-dimensional imaging technology, is the next generation of care.

To view the full article, please click on the button below.

The Room Xchange: The New Way To Experience Travel

10th November 2016, Travel Weekly By Kate Webster

Tourism is an integral part of australian life. Aussies love nothing more than to welcome overseas guests to their beloved land down under. In fact, 7.99 million visitors landed on our shores in the year ending august 2016, which was an 18.9 per cent increase on the previous year (abs overseas arrivals and departures, australia, august 2016.)

When it comes to the big spenders of overseas travel, surprisingly, the millennials trump the baby boomers and come top of the list. Interestingly, millennials tend to shy away from buying luxury goods, such as a car and a house, and are veering more towards a share economy in many aspects of their lives. (Goldman SCHS 2016).

For centuries, people have been happy to share their things with family, friends or even a neighbour in need to reduce costs. Not surprisingly, more and more are seeing the benefits of this living style in many aspects of their lives and choosing to adopt a share economy approach. The travel and tourism industry is seeing the benefits of this fast, expanding concept.

The Room Xchange is a perfect example of this. This innovative business is an online marketplace that connects busy people with a spare room in their house with guests who provide a couple of hours a day of help around the house each day in Xchange for food and accommodation.

To view the full announcement, please click on the button below.

Investors Central – A Smart Road to Wealth

Investors Central is an Australian owned, unlisted public company that raises capital to invest in the national automobile loans market.  Since 2010 Investors Central has achieved steady growth in both revenue and profit on the back of vehicle financing through its’ automobile lending business Finance One.

Investors Central has released the 2016-17 Prospectus offering interest rates up to 14.35%. with terms from 1 year to 5 years.

Highlights of the Year

  • Earned income up to 49.4% to $15.55m
  • Net Profit before tax up 31.0% to $2.75m
  • Net Profit after tax up 30.6% to $1.92m
  • Total Equity up 49.4% to $5.84m
  • Loan Book increased by 55.4% to $57.35m
  • Finance one has firmly established itself as a significant player within the automotive finance market sector.  Finance One currently has over 1070 finance brokers across Australia.

To download the prospectus, please click on the link below. 

Peppermint Innovation Enters Partnership with GCash

19th November 2016, ASX Announcement

Highlights

  • Peppermint to utilise GCash products and services to empower the Peppermint Agent App, a specific technology platform developed and built for established agent networks.
  • Pilot program planned with up to 2,000 agents to examine the benefits of the co-operative effort.
  • Arrangements to increase distribution of GCash’s offering and provide Peppermint Agents with access to GCash’s non-bank network and the ATM network in the Philippines.
  • Potential to increase domestic and international transactions across the Peppermint platform and drive revenues.

Peppermint Innovation Limited (ASX:PIL), (the “Company” or “Peppermint”) is pleased to announce that it has now signed a letter of intent (LOI) with Globe subsidiary G-Xchange, Inc.; provider of Globe’s GCash offering.

To download the full announcement, please click on the link below.

 

Investors Continuing To Back Brisbane’s Middle Ring Despite Media “Oversupply”

9th November 2016, The Urban Developer

Daniel Erez is the Managing Director at Newground Capital Partners, a real estate investment manager with a focus on structured finance and direct property funds. Newground Capital originates, structures and manages both debt and equity capital into opportunistic and value-add real estate investments.

With mainstream media pushing a ‘doom and gloom’ view of the residential property market, it’s easy to understand why sentiment has softened – but recent activity clearly demonstrates that investor confidence in the market remains.

To view the full announcement, please click on the button below.

SUDA Enters Licensing Agreement For ZolpiMist in China

9th November 2016, ASX Announcement

SUDA LTD (ASX: SUD), a leader in oro-mucosal drug delivery, and Eddingpharm (Asia) Macao Commercial Offshore Limited (Eddingpharm), a leading Chinese pharmaceutical company, today announce that the companies have entered into an exclusive license agreement for the development and commercialisation of SUDA’s novel ZolpiMist™ oral spray of zolpidem tartrate to treat insomnia in China. Once approved by the Chinese Food and Drug Administration (CFDA), ZolpiMist would be the first imported fast-acting oral spray of zolpidem tartrate available in China.

Under the terms of the agreement, SUDA receives an upfront cash payment of US$300,000 (approx. A$400,000) and is entitled to receive a further milestone payment of US$200,000 (approx. A$260,000) following registration of the product in China.

To view the full announcement, please click on the button below.

Lonsec Approves DomaCom

7th November 2016, Professional Planner

DomaCom is pleased to announce that Lonsec have reviewed DomaCom’s fractional property investment fund and given it an Approved rating.

DomaCom CEO, Arthur Naoumidis, said, “Whilst we have several reviews and ratings from other agencies which have led 41 AFSLs to place our Fund on their approved product list, the reality is an approved rating from Lonsec will have a greater impact, increasing the number of dealer groups, exposing the Fund to their advisers and giving them more confidence to bring fractional property under their advice”.

To view the full article, please click on the button below.

Thinxtra Launches $5 Million Program to Create Smart Cities in Remote Australia

4th November 2016, StartUp Smart By Dinushi Dias

An Internet of Things (IoT) powerhouse is launching a $5 million program to get 50 Australian councils connected to a network that will ignite new life into dead objects and devices.

Thinxtra is offering to install the SIGFOX network in regional Australian towns that have at least 10,000 residents.

As part of the initiative, the connectivity provider will also give development kits to local accelerators and incubators so they can start building IoT solutions that work with the network.

To view the full article, please click on the button below.

Folkestone Maxim A-REIT Securities Fund – October 2016 Monthly Report

October 2016
Over the 12 month period ended 31 October 2016, the Fund returned +11.20% (after fees, before tax) outperforming the Benchmark return of +6.39% by +4.81%.

The Monthly Report provides a snapshot of the Fund and the A-REIT sector’s performance.
Read more

The Folkestone Maxim A-REIT Securities Fund is a high conviction, actively managed fund, that gives investors exposure to a mix of quality listed A-REITs that own assets across the retail, residential, commercial, industrial and real estate related social infrastructure sectors.

  • Investment Expertise
  • Exposure to Listed Real Estate
  • High Conviction, Active Strategy
  • Daily Liquidity
  • Quarterly Distributions
  • Strategic Capacity Limit

 

Tesserent Sale of Sonar/MyNet IP

8th November 2016, ASX Announcement

  • Tesserent sells Sonar/MyNet IP to Family Zone Cyber Safety Limited (ASX:FZO) for $3.8m, consisting of $3.5m cash and $0.3m in FZO shares, subject to condition precedent.
  • Tesserent continues to sell and fully support Sonar/MyNet services globally and has been appointed as the exclusive reseller of Sonar/MyNet in Australia.
  • Tesserent retains existing education client base and remains focused on education-sector.
  • Substantial cash injection of $3.5m allows Tesserent to optimise market opportunities by making significant investments in its core business as a managed security service provider.
  • Sonar/MyNet sale significantly reduces Tesserent’s overheads for the continued development of the software, through headcount reduction.
  • Model allows Tesserent’s offering to scale profitably on a variable-cost, on-demand basis.
  • Tesserent and Family Zone’s working relationship provides an exciting opportunity to expand the cyber safety market, with technologies designed for use within schools and the home environment.

To view the full announcement, please click on the button below.

Charter Hall Long WALE REIT

8th November 2016, ASX Announcement

Charter Hall Group (ASX:CHC) (Charter Hall or the Group) today announced that following the fully underwritten Institutional and Broker Firm Offers for the Charter Hall Long WALE REIT (Long WALE REIT or the REIT), there has been strong demand totalling $75.7 million from its retail and high net worth clients to participate in the Group Offer and DIF Reinvestment Offer as described in the Supplementary Product Disclosure Statement dated 27 October 2016.

As a result, the Charter Hall Group commitment to be allocated up to $210 million of units in the REIT (being the $ value of equity co-investments rolled into the REIT by the Group) will be reduced to $134.3 million of units in the REIT, representing a 16.24% interest alongside its equity partners.

To view the full announcement, please click on the button below.

Altech Commences Soil Survey at Johor HPA Site

8th November 2016, ASX Announcement

Highlights

  • Altech commences soil drilling and survey at Johor HPA site
  • Requirement as part of detailed civil design and engineering
  • M+W Group (Singapore) co-ordinating work

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to advise that it has commenced soil survey drilling at the site of its proposed high purity alumina (HPA) plant in the Tanjung Langsat Industrial Complex, Johor, Malaysia.

Site topography, soil stability and soil analysis are required to finalise the HPA plant civil design and engineering. The Singapore office of M+W Group, Altech’s engineering, procurement and construction (EPC) contactor, is coordinating the drilling, soil studies, civil design and engineering work. The work will include a full analysis of the soil profile of the site and a determination of the piling and civil requirements.

To view the full announcement, please click on the button below.

Meme Australian Share Fund October Factsheet and Performance Review

INVESTMENT OBJECTIVE: To outperform the S&P/ASX All Ordinaries Accumulation Index over rolling three year periods, through active investment in ASX listed securities outside the S&P/ASX 20.

INVESTMENT APPROACH: The Fund takes an evidence-based quantitative approach to investing and uses a robust and back-tested trend-following strategy to identify investment opportunities expected to provide both positive price appreciation and relative price outperformance over the medium to long term. The Fund rigorously applies a set of capital management rules to manage both risk and return such that any losses are taken while they are small while gains are given room to compound until their long-term price trends become exhausted or their relative out-performance becomes impaired.

To view the full announcement, please click on the button below.

YPB Signs Supply Agreement with Orora

7th November 2016, ASX Announcement

  • In May 2016 YPB announced the signing of a Memorandum of Understanding (‘MOU’) with packaging company Orora (ASX: ORA)
  • MOU now superseded by Supply Agreement
  • YPB to offer full suite of products to Orora customers

Brand Protection and Customer Engagement solutions company YPB Group Limited (ASX: YPB) is pleased to confirm that following the signing of an MOU with Orora Limited (ASX:ORA) in May, a Supply Agreement for YPB’s full PROTECT, DETECT, CONNECT solutions suite has now been executed. Under the agreement YPB and Orora will partner to take YPB’s Brand Protection and Customer Engagement solutions to Orora’s customers.

To view the full announcement, please click on the button below.

Leaf Resources Voted World’s 4th Hottest Emerging Company

7th November 2016, ASX Announcement

Leaf Resources (ASX:LER, “Leaf” or the “Company”) is pleased to announce that it has been voted number 4 in the 2016-2017 Top 40 Hottest Emerging Companies in the Advanced Bioeconomy during the Advanced Bioeconomy Leadership Conference in San Francisco.

This is the second consecutive year Leaf has been voted into the Top 40 list with the Company climbing to fourth place from number 32. This renewed recognition signifies the progress Leaf Resources has made in the last 12 months towards the commercialisation of their Glycell technology and the recognition by the industry of the importance of the Glycell process.

To view the full announcement, please click on the button below.

Alcidion to Conduct WA Roadshow and Meeting with WA Minister for Health

7th November 2016, ASX Announcement

Alcidion Group Limited (ASX:ALC) today announced a two-day roadshow aimed at extending relationships in Western Australia.

Executive Director and CEO of Alcidion, Mr. Ray Blight will be meeting with numerous stakeholders throughout the state health system, both public and private, over the two-day trip.

Meeting with WA Minister for Health

We are also very excited that we have secured a meeting with West Australian Minister for Health, the Hon. Jon Day on Tuesday, 15th November 2016.The meeting will be an opportunity for Alcidion to explore the WA health system and understand its goals and future focuses.

To view the full announcement, please click on the button below.

GetCapital Awarded 2nd Fastest Growing Company in Australia

7th November 2016

GetCapital has been recognized as the Australia’s 2nd fastest growing business in SmartCompany’s 2016 Smart50 Awards.

The Smart 50 Awards celebrate smart, innovative and fast-growing SMEs and this year the awards attracted more than 200 entrants. Finalists were ranked according to overall growth over a three-year period and GetCapital secured second place, thanks to an overall growth rate of 949% achieved over the past 3 years.

Jamie Osborn, GetCapital Chief Executive Officer said the award is a testament to a hardworking and talented team.

“We are very pleased to receive the recognition for the growth that GetCapital has been able to achieve over the past 3 years. It is a strong endorsement of the hard work of the entire GetCapital team. That said, we are only in the first innings of our company’s development and our focus is very much on the next 3 years of our growth story”.

‘We have a number of key initiatives underway to further improve the delivery of our products and services to our clients and partners. It’s an exciting time for our company and there are some very big things planned for 2017.” he said.

AsiaPhos Signs MOU with Key Customer

4th November 2016

AsiaPhos Limited (“AsiaPhos” or the “Company”, and together with its subsidiaries, the “Group”), a Singapore-headquartered mineral resources company focused on exploring and mining phosphate with a vertically-integrated business model, today announced that its wholly-owned subsidiary, Sichuan Mianzhu Norwest Phosphate Chemical Limited (“Mianzhu Norwest”), had on 3 November 2016, entered into a non-binding memorandum of understanding (“MOU”) with Mianyang Aostar Phosphorus Chemical Industry Co., Ltd. (绵阳启明星磷化工有限公司) (“Mianyang Aostar”), to collaborate on certain initiatives in relation to the Group’s operations.

The initiatives under the MOU include (i) promoting the development of the market for Pin the People’s Republic of China (“PRC”); (ii) the supply of phosphate rocks by Mianzhu Norwest to Mianyang Aostar; (iii) the purchase of phosphate-based chemical products from each party to satisfy third party orders; and (iv) the purchase of electricity by Mianzhu Norwest by leveraging on Mianyang Aostar’s existing electricity arrangements, details of which are as further described below.

Mianyang Aostar is one of the biggest manufacturers in the PRC of yellow phosphorus, phosphoric acid and related phosphate products and purchases phosphate rocks from the Group.

Dr Ong Hian Eng (王显荣博士), Chief Executive Officer of AsiaPhos Limited said,

“This MOU formally seals the close and longstanding relationship we have with Mianyang Aostar, which is one of our key customers. The considerable synergies we have offer many partnership opportunities, which we believe can help to achieve better market positioning, competitive advantages and cost savings, amongst other benefits. We are confident that this will be a mutually-rewarding collaboration and over time, will enhance the Group’s performance.”

Collaboration Initiatives

The collaboration initiatives contemplated under the MOU include the following:

1.      Mianzhu Norwest and Mianyang Aostar will seek to enhance communication of information between them in relation to the market for P4 in the PRC, with the aim of establishing reasonable pricing and the prevention of unfair competition.

2.      Mianzhu Norwest will prioritise the fulfilment of purchase orders from Mianyang Aostar for phosphate rocks from the Group, subject to the Group’s internal requirements. Under the MOU, Mianyang Aostar has indicated that it may purchase approximately 20,000 tonnes of phosphate rocks and up to 100,000 tonnes of phosphate rocks from the Group in the remaining months of 2016 and in 2017 respectively.

3.      Mianzhu Norwest and Mianyang Aostar will seek to purchase phosphate-based chemical products from each other to satisfy orders which are in excess of their respective available inventory or capacity (where applicable).

4.      Mianzhu Norwest will explore the purchase of electricity at preferential rates, by leveraging on Mianyang Aostar’s existing electricity arrangements.

Long Pipes Fluid Highway Wins at the Australian Technologies Competition

At the Australian Technologies  Competition, Showcase and Awards event, held at the  Australian National Maritime Museum, Darling Harbour, Sydney on Wednesday 2nd November 2016 Long Pipes Fluid Highway was awarded the:-

People’s Choice  Award, by the audience of 220 people with representatives from the Australian Government, The UK Government, VC’s, Investment institutions, banks, private investors and other competitors who represent some of Australia’s top technology companies.  Long Pipes presenter Neil Graham was presented with the award by Mr Paul Hogan as the representative for the NSW Government and was informed that the support for Long Pipes by the audience had been overwhelming.

The Energy Resources Award, from the Oil, Gas, Coal and Uranium industry; was awarded by Jill Stejduhar General Manager of  the of National Energy Resources Australia (NERA)  (a federal government body) who said that the judges considered that Long Pipes was “head and shoulders the winner”.

Long Pipes is proud to be a recipient of these awards from the Australian Technologies Competition audience and judging committee.

Tesserent Appointed as Alienvault Platinum Partner

3rd November  2016, ASX Announcement

Highlights:

  • AlienVault has appointed Tesserent as a Platinum Partner.
  • AlienVault technology will be used to provide new products and services to Tesserent’s customers.
  • This partnership adds unified security management, security information and event management (SIEM) and enhanced threat detection to Tesserent’s managed security offering.

Tesserent Limited (ASX: TNT) is pleased to announce that it has signed an agreement with AlienVault®, a leading provider of Unified Security Management (USM)TM as a Platinum Partner. The AlienVault USM platform enables Tesserent to quickly deploy and efficiently monitor customer environments. With robust and integrated asset discovery, vulnerability assessment, behavioural monitoring, SIEM, intrusion detection, and threat intelligence capabilities, AlienVault USM will expand and enhance Tesserent’s service offerings.

To view the full announcement, please click on the button below.

Bulletproof 2016 AGM Chairman’s Address & Presentation

3rd November 2016, ASX Announcement

  • It has been a very busy and successful year for Bulletproof, a year with quality growth as a focus and 2017 should see more of the same.
  • Highlights since the last AGM on 13 November 2015 include:
  • The acquisition of the business assets of Cloud House (Completed Feb 2016), giving Bulletproof an immediate presence as the only Premier Consulting partner for AWS in New Zealand, and brought on a number of high quality customers such as Xero.
  • Successful integration of the Infoplex acquisition, completed in October 2015, now fully integrated with the launch of Bulletproof’s new Private Cloud offering.
  • Record revenue growth for FY16 to $47.2m, compared with $28m in FY15, a growth rate of 69%, 31% being organic growth.
  • Winning the 2015 Frost & Sullivan Managed Cloud Provider of the year award, recognising the Company’s longstanding record of success, experience and industry leadership.
  • Successful production deployment of our Sell Anywhere retail integration product into Myer and other retailers.
  • Acquisition of several blue chip customers such as Xero, Adairs and Genworth increasing our customer count to over 750.  Consolidation of our Sydney head office from three locations into a single new CBD space in June.
  • Successful launch in recent days of Microsoft Azure product offering

To view the full announcement, please click on the button below.

To view the full Presentation, please click on the button below.

Crowd Mobile and MTV International Partnership

3rd November 2016, ASX announcement

Highlights

  • First six apps ‘Geordie Toon’ and ‘Geordie Stars’ released under Crowd Mobile’s partnership with Viacom International Media Networks (VIMN)
  • ‘Geordie Toon’ is a freemium app featuring more than 500 personally curated stickers of ‘Geordie Shore celebrities which is MTV International’s top-rated program in the UK
  • The sticker app will include a photo-editing feature and a world-first Q&A feature inspired by the stars
  • The Q&A feature will allow fans to ask their favourite MTV celebrities questions and receive personalised answers
  • Additional app releases under partnership are expected over the coming months

Crowd Mobile Limited (ASX: CM8 & FWB: CM3) (Crowd Mobile or the Company) is delighted to announce the first app releases from its partnership with Viacom International Media Networks (VIMN), the international division of Viacom Inc. (NASDAQ:VIAB and VIA) [ASX Announcement: 10 October, 2016].

To view the full announcement, please click on the button below.

Catcha Group Partner Bulletin – November 2016

IFLIX STREAMING TARGETS EMERGING MARKETS

CNN
Patrick Grove speaks to CNN about what iflix is doing to set itself apart in emerging markets.
Watch here

FRONTIER DIGITAL VENTURES PARTICIPATES IN CAPITAL RAISING BY ZAMEEN

e27
Frontier Digital Ventures today announced that it is going to participate again in a fundraising round for Zameen, a leading property portal in Pakistan.
Read more

Patrick Grove talks about iflix, the leading OTT service in ASEAN 
Vanity Fair Hive · Watch here

iflix is focused on Southeast Asia
Cheddar · Watch here

iflix all set to start its services in Pakistan
Tech Juice · Read More

Azran, CEO of iflix Malaysia on diversifying strategy to stay ahead of the game
Vulcan Post · Read here

meQasa celebrates 3 years of changing real estate in Ghana
Business Ghana · Read here

Frontier Digital Ventures increases stake in Moroccan car classifieds startup Moteur
Disrupt Africa · Read here

More Catcha Group coverage here

 

DomaCom To List on ASX Today!

DomaCom Limited will formally be admitted to the official list of the ASX at 11am today.

The listing code will be DCL and the listing price is $0.75c per share.

The IPO is an exciting milestone in DomaComs history and we look forward to an exciting couple of years ahead as they strive to deliver on the significant potential of the company.

DomaCom raised $7.33 million through their IPO offer which closed on October 24.

This injection of capital will position DomaCom for its next growth phase – to commence more property bookbuilds and, subject to regulatory approvals, launch a seniors equity release product and a fractionalised corporate bond product.

Having acted as lead manager to the pre-IPO funding rounds, Axstra Capital is proud to have assisted DomaCom in reaching this point in their corporate journey and thanks all investors who have financially supported the company to date.

It is our opinion that the IPO is just the beginning for DomaCom and the upside potential for the share price is significant should they be able to deliver on the objectives outlined in the prospectus.

Crowd Mobile Appoint Non-Executive Director

2nd November 2016, ASX Announcement

Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) (Crowd Mobile or the Company) is pleased to announce that Ms Sophie Karzis, the Company Secretary of Crowd Mobile, has been appointed as Non-Executive Director on the Company’s Board.

Ms Karzis is a practising lawyer with over 20 years’ experience as a corporate and commercial lawyer. She is the principal of the law firm Corporate Counsel Pty Ltd which she founded in 2004, and is a member of the Law Institute of Victoria and the Institute of Chartered Secretaries.

Ms Karzis has considerable expertise in providing corporate governance advice to ASX listed entities, and currently acts as company secretary and in-house counsel for a number of companies listed on the ASX.

To view the full announcement, please click on the button below.

SUDA Files Patent Application For Novel Mucosal Penetration Technology

2 November 2016, ASX Announcment

SUDA LTD (ASX: SUD), a leader in oro-mucosal drug delivery, today announced that it has filed a provisional patent application with IP Australia for a novel mucosal penetration drug delivery technology. The application was filed under the international Patent Cooperation Treaty (PCT), which enables SUDA to seek patent protection for its technology in more than 145 countries.

The technical field of the provisional patent application is entitled: ‘A method for modifying the penetration of active agents through mucosal membranes using hydrotopes.

To view the full announcement, please click on the button below.

Altech Opens Malaysian Subsidiary Office

2nd November 2016, ASX Announcement

Highlights

  • Altech opens Malaysian subsidiary office in Johor
  • Office situated close to site of proposed HPA plant
  • Malaysian based project coordinator appointed
  • Applications for various permits and approvals commenced

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to announce that it has opened an office for its wholly owned Malaysian subsidiary company Altech Chemicals Sdn Bhd in Johor, Malaysia. The office is conveniently located approximately 300 metres from the site of Altech’s proposed high purity alumina (HPA) plant in the Tanjung Langsat Industrial Complex, Johor, Malaysia

To view the full announcement, please click on the button below.

Aeeris Quarterly Report for Q1 Ended 30 September 2016

31st October 2016, ASX Announcement

Financial Highlights

  • Total cash receipts of $270,205
  • Receipt of $589,057 cash R&D Tax Rebate since the end of the Reporting Quarter, received on 14 October 2016
  • Cash position at date of this Announcement of $1.519 million (unaudited)
  • Net decrease in cash held during the Reporting Quarter of $625,170, compared with $429,971 in the previous quarter
  • Cash position at end of quarter (30 th September 2016) of $1.11 million (unaudited)

Business Highlights

  • Much activity during the reported Quarter was focused on technology R&D and software development attached to some major new business opportunities. Delays in this production process stalled new revenues from other sources. This factor, combined with the decision not to renew the Brisbane City Council service, has impacted revenues for the Quarter.

To view the full announcement, please click on the button below.

YPB Company Update October 2016

31st October 2016, ASX Announcement

Brand Protection and Customer Engagement solutions company YPB Group Limited (ASX: YPB) is pleased to provide a summary of activities for the quarter ended 30 September 2016

Key achievements for the quarter included:

  • Concluding a three year supply agreement with TGA-accredited manufacturer Universal Pharmaceuticals Ltd for Brand Protection and Customer Engagement technologies.
  • Partnering with Impact International to offer YPB’s full solutions suite to its customers, which includes many of Australia and New Zealand’s leading manufacturers of cosmetics, fast moving consumer goods, pharmaceuticals, health products and nutraceuticals.
  • Rolling out YPB’s Lexcaps re-usable security cap as an anti-theft device across the Dan Murphy’s retail chain.
  • Secured the first commercial contract in Mexico, as part of the Affyrmx JV, to supply YPB’s proprietary tracer solution to PROTECT redeemable food coupons against counterfeits.
  • Winning the first entertainment sector contract to PROTECT entry tickets for a major, private Beijing museum, with YPB’s tracer solution.
  • Signing a three year agreement with Combiphar, a leading Indonesian pharmaceuticals and wellness company, for the supply of Brand Protection and Customer Engagement technologies.

To view the full announcement, please click on the button below.

Avenir Capital September 2016 Quarterly Investor Update: +13.5%

28th October 2016

The Avenir Value Fund (the “Fund”) increased 13.5% in the September 2016 quarter, gained 13.1% in the calendar year-to-date and has returned 90.8%, net of fees and expenses, since the Fund’s inception in August 2011. By comparison, the ASX All Ordinaries increased 5.3% in the quarter, 6.9% year-to-date and 52.6% since the Fund’s inception. The MSCI World Total Return index returned 7.5% for the quarter and 44.3% since the Fund’s inception. The quarter marked the 5-year anniversary of Avenir’s inception.

During that time we have done some things very well and some things that we could have done better. We have worked continuously to refine our process as part of the never ending quest to reduce risk and improve performance. What has not changed during our five years, however, is our steadfast belief in the value of investing with a value oriented mindset.

To view the full announcement, please click on the button below.

iFAST Corp Reports Net Profit Improved By +59.3% in 3Q2016

28th October 2016, iFAST Corporation Ltd

iFAST Corporation Ltd. (“iFAST Corp” and together with its subsidiaries, the “Group”) reported its financial results for the third quarter (3Q2016) and first nine months of 2016 (9M2016).

Highlights:

  • Following a difficult 1H2016, the Group (excluding its recently-launched China operation) reported a 59.3% increase to S$2.97 million in 3Q2016 net profit from S$1.87 million in 2Q2016
  • The Group (ex-China) saw its net revenue increase by 10.3% QoQ, while AUA increased 6.6% QoQ to a record S$6.00 billion as at 30 September 2016
  • Compared to a year ago, the Group’s net profit (ex-China) declined 8.4% YoY in 3Q2016, as its efforts to improve the range of investment products and services continued
  • After the launch of stockbroking capabilities on the Hong Kong B2B platform and insurance products on the Malaysia B2C platform, the Singapore operation is targeting to launch its stockbroking capabilities in end-2016 /early-2017
  • The contribution from the relatively newer investment product categories (Bonds/ETFs/Stocks) stood at a combined 6.8% of the Group’s AUA as at 30 September 2016
  • The Directors believe that the Group has a strong balance sheet. Total Cash and other investments stood at S$57.01 million as at 30 September 2016
  • The Directors have proposed a third interim dividend of 0.68 cents per ordinary share for 3Q2016 (3Q2015: 0.68 cents per ordinary share)

To view the full announcement, please click on the button below.

Leaf Resources Raises $2.35m in Placement

31st October 2016, ASX Announcement

Leaf Resources (ASX: LER, “Leaf” or the “Company”) is pleased to announce that is has successfully raised $2.35 million, through a placement of 16.2 million ordinary shares to sophisticated investors.

The placement was priced at $0.145 per share, which reflected a 12.2% discount to the 30-day volume weighted average price (VWAP) and a 14.7% discount to the last closing price of $0.17, prior to the raise being announced on 26th October. Two directors have participated in the raising to a value of $146,000 and the issue of those shares will need to be approved at a forthcoming EGM.

To view the full announcement, please click on the button below.

YuuZoo Signs Agreement to Become Biggest Shareholder of Relativity Media

30th October 2016, Business Wire

  • Deal will create a new end-to-end global leader in content and distribution
  • Relativity’s world-leading content will feed directly into YuuZoo’s huge global distribution network, covering 69 countries with 4.3 billion consumers
  • YuuZoo’s global payment platform YuuPay will be used for all of Relativity’s online and mobile payments

Add before the Relativity boilerplate: “The transaction was sourced by Global Emerging Markets (“GEM”), a $3.4 billion alternative investment group and YuuZoo investor that manages a diverse set of investment vehicles focused on emerging markets across the world. GEM also played a key role in the structuring of the deal.” Also, please note that a boilerplate for GEM has been added to the very end of the release.

To view the full announcement, please click on the button below.

Leaf Resources September Update 2016

31st October 2016, ASX Announcement

Highlights:

  • Game changing period for Leaf as it signs JV agreement with leading USbased chemical project developer Claeris, LLC.
  • Company well-funded to achieve next set of commercial milestones as its cash holding is bolstered by the successful completion of a $2.35m capital raise.
  • Significant milestones achieved post September quarter with strong pipeline of potential announcements in the near term.

Leaf Resources (ASX: LER, “Leaf” or the “Company”) is pleased to provide the following update on its activities for the three months ended 30th September 2016. The Company reached an inflection point in the commercialisation of its proprietary GlycellTM technology in the past few months.

To view the full announcement, please click on the button below.

Tesserent Quarterly Activities Report; Sales Increased By 12%

31st October 2016, ASX Announcement

Tesserent Limited (ASX: TNT) is pleased to deliver the September Quarterly Financial and Activities Report, highlighted by execution of the Company’s planned growth strategy and an increase in quarterly sales by 12%.

Key highlights during the quarter:

  • Customer receipts increased by 12% on previous quarter from $1.107m to $1.240m
  • Quarter on quarter receivables maintained at stable rate
  • Asian markets Business Development Manager appointed
  • Renewed and upgraded several existing customers • Continue to sign-up new customers
  • US channel partner commences, delivering solid growth

To view the full announcement, please click on the button below.

 

Spirit of Tasmania Awards Contract to Aeeris

31st October 2016, ASX Announcement

Aeeris is pleased to announce that TT-Line Company Pty Ltd has chosen Aeeris and Early Warning Network to provide the Spirit of Tasmania shipping line with tailored 24×7 severe weather forecasting, monitoring and alerting services.

Spirits of Tasmania I and II provide the principal passenger and cargo shipping operation between the Australian Mainland and Tasmania.

This contract is significant in placing Aeeris and Early Warning Network at the forefront of maritime safety in Australia. We aggregate weather data from multiple sources to put on the smartphones carried by the ships’ Masters the intelligence they need to maintain safety and increase efficiencies when both at sea and in port.

To view the full announcement, please click on the button below.

Peppermint Innovation September 2016 Quarterly Review and Appendix 4C

31 October 2016, ASX Announcement

Peppermint Innovation Ltd (ASX: PIL) (the Company or Peppermint) has today lodged its Appendix 4C Report for the period ended 30 September 2016 and is pleased to provide a review of its progress for the quarter.

Highlights:

  • Named by Forbes Philippines as one of the Top 24 Fintech start-up companies in the Philippines.
  • Strong revenue growth of 17% for the quarter, driven by a 20% increase in transaction volumes.
  • UnionBank initiatives developed and implemented to drive account holder registration to its target of 2.5 million registered users to the UMobile app powered by Peppermint’s mobile banking and payments platform.
  • On-boarding of Bayad Center billers commenced with 13 billers added during the quarter.
  • Agent registration for the MyWeps app, powered by Peppermint’s mobile payments and remittance platform is ongoing with Peppermint assisting MyWeps to on-board agents, add new billers and progress the requirements of the market regulator to implement a pilot mobile remittance program for agents.
  • Strategic partnership with UCPB Bank extends offering to include ‘Peppermint Fast Remittance System’ and international remittance capability
  • The Company remains well funded, with over $1.61m of cash in the bank.
  • International payments expert Mr Rod Tasker appointed as Non-Executive Director and Strategy Advisor, with immediate focus developing the Australian business operations.

To view the full announcement, please click on the button below.

SUDA Appendix 4C For First Quarter FY2017

31 October 2016, ASX Announcement

SUDA Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, today released its Appendix 4C for the consolidated Group for the first quarter of FY2017. Receipts from customers for the period were $1.6 million, an increase of 25% from the first quarter of FY2016.

The Company reduced its net operating cash loss to $0.25 million in the first quarter compared to $0.61 million in the previous corresponding period of FY2016. Net cash used in investing activities was $0.29 million for the quarter. The cash position as at 30 September 2016 was $1.9 million.

To view the full announcement, please click on the button below.

Altech Chemicals Quarterly Activities and Cashflow Report

31st October 2016, ASX Announcement

HIGHLIGHTS

Altech targets increased project debt of US$70 million

  • Altech targeting total project debt of US$70m
  • Export credit cover component increased to US$60m
  • Uncovered debt portion of up to US$10m
  • Simplified sole lender structure proposed for the US$70m of debt by KfW IPEX-Bank

Positive pre-assessment of Altech’s US$60m export credit application

  • Positive pre-assessment of ECA application by German inter-ministerial committee
  • Important milestone in the credit cover application assessment process
  • Initiates project detailed due diligence

Appointment of due diligence consultants

  • Lenders’ due diligence consultants appointed
  • Technical, market and legal due diligence commenced
  • Due diligence initiation meeting held in Stuttgart, Germany
  • Site visits to Meckering and Johor completed

To view the full announcement, please click on the button below.

DomaCom: Residential Property Improves Portfolio Performance

27th October 2016, Professional Planner

A report by Aitchison Consultants has shown that the inclusion of residential property in a portfolio can enhance performance in moderate, balanced and growth investment portfolios.

The report supports property as an inclusive strategy and that residential property with it’s relatively low volatility provides a stable anchor to these portfolio types.

The figures taken over a rolling 20 year period with different asset allocations show a decidedly positive result. A growth portfolio with 20% to real property could be improved by up to to 9.6%, a balanced portfolio with 15% could show a 6.7% improvement and a moderate portfolio with only 10% exposure a 3.7% uplift.

DomaCom CEO, Arthur Naoumidis, said that “DomaCom is the ideal vehicle to control asset allocation in real property without the client’s need to borrow if that is deemed an inappropriate strategy. ”

To view the full announcement, please click on the button below.

MedAdvisor Completes Healthnotes Acquisition

31st October 2016, ASX Announcement

MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication management company, is pleased to announce it has completed the acquisition of Health Enterprises 2 Pty Ltd (“Healthnotes”), a leader in healthcare technology for medication adherence.

The acquisition was for a total consideration of $5.5 million, paid as 60% cash and 40% scrip. 57,894,737 shares have been issued to the Healthnotes vendors at $0.038 a share and a $3.3 million cash consideration has been paid. A further $0.7m in transaction costs have also been paid for a total cash outflow of $4m.

To view the full announcement, please click on the button below.

Proteomics Wins WA Exporter of the Year

31st October 2016, ASX Announcement

Medical technology company Proteomics International Laboratories Ltd (ASX: PIQ) has edged out shipbuilding giant Austal and Fortescue Metals Group to win the WA Exporter of the Year Award.

The company also took out the Health and Biotechnology category of the WA Industry and Export Awards for the second year running for outstanding international success.

“It’s fantastic to be recognised for our world-leading capabilities in delivering specialist analytical services, combined with our new innovations in medical technology,” said PILL managing director Dr Richard Lipscombe.

“The awards highlight our growing export achievements in emerging markets, such as the Middle East, on top of our established strength across the Asian region.”

To view the full announcement, please click on the button below.

Martin Aircraft Company 2016 AGM Presentation

27th October 2016, ASX Announcement

Chairman’s Address

Let me start by making it very clear that your Board is not happy with the progress made by the Company to the end of the financial year. We acknowledge that there have been delays to date with commercialisation and a re-working of some of the aircraft’s specifications. Our absolute focus needs to be in getting an airworthy product to market with the company able to market sales of the aircraft on the back of this.

As your Chairman, I acknowledge my own and the boards responsibility with the delays in progress.

As a result of these issues the Board undertook a strategic review of the Company’s progress in August 2016, in particular focusing on how to best progress the path towards commercialisation of the Series 1 Jetpack whilst effectively managing its cost base.

To view the full announcement, please click on the button below.

Iconic Melbourne Restaurants Join with Delivery Platform Endulj

27th October 2016, Hospitality Magazine By Madeline Woolway

MoVida (Frank Camorra), Pei Modern (Mark Best), Lee Ho Fook (Victor Liong), Thirty Eight Chairs (Mirco Speri), Tokyo Tina and Saigon Sally (Adrian Li) have joined with Endulj to deliver their dishes along with matched wines.

Endulj uses its purpose-built Windsor based $400,000 kitchen headed up by executive chef Matt Germanchis (Pei Modern, The Fat Duck, MoVida) to make dishes from each restaurant, which have been designed for delivery and are made to order.

To view the full announcement, please click on the button below.

The Room Xchange Set to Shake up Australia’s Housing Crisis

25th October 2016, LinkedIn By Ludwina Dautovic

It’s a little known secret that the cost of living in Australia is on a continual rise. The effects of this can be seen across the country and through all walks of life.

For years, people have been happy to share their things with family, friends or even a neighbour in need in order to reduce costs. Not surprisingly, more and more are seeing the benefits of this living style in many aspects of their lives and choosing to adopt a share economy approach.

With an increased shortage of affordable housing up and down the country the share economy is a solution to this problem. Although it’s hard to believe there is such a shortage given that there are 7,000,000 houses with spare rooms in Australia. So what is the solution to this problem?

To view the full announcement, please click on the button below.

Offers for Charter Hall Long WALE REIT Fully Underwritten

27th October 2016, ASX Announcement

Charter Hall Group (ASX:CHC) (Charter Hall or the Group) today announced that the Institutional and Broker Firm Offers for the charter Hall Long WALE REIT (Long WALE REIT or the REIT) have been fully underwritten. In addition, binding subscriptions have been received from institutional vendors (including Charter Hall) for thee balance  of the IPO.

Long WALE REIT will have  a forecast forecast operating earnings yield of 6.3% annualised from the period from Allotment to 30 June 2017 and 6.4% annualised for 1H FY18. At Allotment, the REIT will have 22.9% balance sheet gearing and look through gearing of 35.0%.

A Supplementary Product Disclosure Statement for the REIT is expected to be lodged with the ASX by 28 October 2016.

To view the full announcement, please click on the button below.

Altech Chemicals’ Managing Director Iggy Tan Interviewed at TechKnow Invest Conference

27th October 2016, ASX Announcement

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) advises that an interview featuring managing director Mr Iggy Tan was conducted at the recent TechKnow Invest conference and is now available for viewing on the Company’s web site (www.altechchemicals.com).

In the interview Iggy provides an overview of for factors underpinning global high purity alumina (HPA) demand, the Company’s plans for a HPA plant in Malaysia and the near term prospects for the Company.

To view the full announcement, please click on the button below.

Mobotech Project Update

As outlined, over the past couple of months Mobotech and Magline have been carrying out demonstrations and tests, under a non-disclosure agreement (NDA), with PepsiCo in Texas.

These tests have formed part of a Pepsi corporate/national initiative called the Driver Unload Project. This is a six-sigma shaped project with goals, objectives and measures of success to determine optimal tools and processes to;

  • Reduce driver fatigue.  50% of delivery time is spent walking to/from trailer.
  • Reduce accidents & injuries (workman comp claims) from repetitive action and fatigue.
  • Reduce unload time – efficiency and productivity gains.

The Mobot is seen as an autonomous “rideable” solution that is ideally suited to address these key “now” issues as well as take advantage of “future” technology opportunities.

The project is being led by a Pepsi LSS team and Maglines’ Director of New Product Development (NPD) has a position on that team. The Team meet again early next month at the Pepsi Knoxville distribution center to further develop the spec’s for the Mobots end effectors.

The Pepsi opportunity is a fortuitous development as we enter negotiations on the longer term contract between Mobotech and Magline. I’ll be in-touch with the outcome of these in due course.

The opportunity of course, to invest some more remains open should anyone wish to take advantage of this timely low-risk, high-return opportunity.

BPS Trading Update and Profit Guidance

26th October 2016, ASX Announcement

Highlights of 1HFY17 guidance:

  • 120% increase in revenue against the prior six month period
  • 48% increase in EBITDA against the prior six month period
  • 15% increase in earnings per share against the prior six month period
  • The $5m Convertible Note that was issued in December 2015 will be redeemed on 12 December 2016

BPS Technology Limited “BPS” (ASX:BPS) is pleased to update the market on the outlook for the first half of FY17 after a better than expected first quarter. The upcoming half-year results will be the first that include the acquisition of Entertainment Publications of Australia and New Zealand “EPANZ” as announced to the market on 12 August 2016.

To view the full announcement, please click on the button below.

MedAdvisor AGM CEO Presentation

26th October 2016, ASX Announcement

FY16 Results Overview

  • Total revenue of $1.76m, representing a 24% increase on FY15 on a normalised basis
    - Normalised basis excludes a final license fee payment of $500,000 from FY15 revenue of $1.9 million
  • Revenue from pharmacy subscriptions and patient engagement programs (PEP) up 24% to $1.43 million
    - Additional revenue streams expected to go live during FY17
  • Gross profit of $925k, up 133% on FY15
  • Gross margin from pharmacy subscriptions increased to 71%, from 43% in the prior corresponding period
  • Net loss of $3.07 million due to increased costs and investments in expanding marketing and sales initiatives for further expansion in FY17

To view the full announcement, please click on the button below.

Crowd Mobile Quarter Trading Update September 2016

26th October 2016, ASX Announcement

Operational Highlights

  • Executed partnership agreement with Viacom International Media Networks, the international division of Viacom Inc. (NASDAQ:VIAB and VIA)
  • Executed China partnership agreement with SmartTrans Holdings Limited (ASX: SMA)

Financial Highlights

  • Quarterly revenue of $10.6 million and underlying EBITDA of $2.2 million
  • Completed debt re-financing with additional working capital availability
  • Equity raisings totaling $3.0 million
  • Maintained continued positive operating cash flow generation
  • Commenced Convertible Note repayments in cash – Net Debt now $12.5 million
  • Strengthened balance sheet with lower gearing and improved working capital ratios

To view the full announcement, please click on the button below.

Alcidion TechKnow Invest Roadshow Recording

26th October 2016, ASX Announcement

Alcidion Group Limited (ASX:ALC) presented at the TechKnow Invest Roadshow in Melbourne, Sydney and Brisbane last week, 18 , 20 and 21 October 2016.

Alcidion had a successful week at the TechKnow conference and with over 600 investors in attendance, Executive Director Mr. Nathan Buzza and Non-Executive Director Mr. Brian Leedman were busy educating potential investors about the company.

Mr. Buzza presented on behalf of Alcidion. Updating the group on the latest developments within the company, Alcidon’s first year as a listed company and milestone targets for FY17.

To view the full announcement, please click on the button below.

LatAm Autos Launch MotorCredit Finance Product

26th October 2016, ASX Announcement

Highlights:

  • Successful launch of pioneering auto finance product MotorCredit, in partnership with Ecuador’s largest financial institution Banco Pichincha
  • An estimated A$150m1 of cars are sold through our websites each month, highlighting the significant potential of auto finance as a revenue stream
  • New product offering will provide a complementary revenue stream, revolutionise used car financing in Latin America and accelerate the path to profitability

LatAm Autos Limited (ASX: LAA) (“LatAm Autos” or the “Company”) is pleased to announce the launch of MotorCredit, a new auto finance product. The product leverages off the dominant market position of the Company’s Ecuadorean business patiotuerca.com and has been developed in conjunction with the largest financial institution in Ecuador, Banco Pichincha.

To view the full announcement, please click on the button below.

LatAm Autos Investment Highlights

26th October 2016, ASX Announcement

LatAm Autos Limited (ASX: LAA) (“LatAm Autos” or the “Company”), the leading online auto classifieds business in Latin America, is pleased to release a new investor presentation attached to this announcement following the release of MotorCredit today. The presentation outlines a compelling investment case which will be presented today at the Wholesale Investor conference in Melbourne, Australia.

Highlights

  • The leading dedicated online auto-classifieds and content platform in Latin America (ex Brazil) with operations in six countries
  • Accelerating path to profitability with near term visibility of A$30m p.a. revenue from both core auto-classifieds and related revenue streams
  • Highly credentialed and well aligned Board and management team (shareholding of c. 42%)
  • Investment has been made in scalable technology platform so marginal revenue expected to be increasingly profitable
  • Increasing internet penetration and regional GDP per capita growth underpin rapid growth of the Latin American auto-classifieds industry
  • Management team has unrivalled experience in founding, developing and monetising online classifieds businesses in Latin America

To view the full announcement, please click on the button below.

YPB Secures $4M Placement At 51.5% Premium

26th October 2016, ASX Announcement

Highlights 

  • $4M placement to existing sophisticated shareholder at $0.25, a 51.5% premium to last traded price
  • Four out of the money options issued per share

Brand Protection and Customer Engagement solutions company YPB Group Limited [ASX: YPB] has completed a A$4 million placement to an existing shareholder.

A total of 16 million ordinary new shares will be issued at $0.25 per share, a 51.5% premium to the last closing price of $0.165.

Each share issued has four attached out of the money options with strike prices of $0.35, $0.45, $0.55 and $0.65, spread equally with a 10 year expiry.

To view the full announcement, please click on the button below.

Altech Company Presentation – ASX Spotlight Series Asia

25th October 2016, ASX Announcement

Sapphire Gemstone

  • Sapphire & Ruby
  • Natural form of high purity alumina (HPA)
  • Formed by mother nature like diamonds
  • Colour from impurities
  • Nearly as hard as diamond (Moh 9)

What’s HPA?

  • Purified alumina
  • Greater than 99.99% (4N) purity
  • Smelter Grade Alumina (SGA) ~ 99.5% (5,000 ppm impurities mainly sodium)
  • Bayer Process uses sodium hydroxide (NaOH)
  • Sodium impurity is problem for electronics industry

To view the full announcement, please click on the button below.

Stashd Featured on China’s Largest English Speaking News Channel

24th October 2016, CCTV By Lui Kai

Australia is urging its businesses and companies to think innovatively when considering China. That’s because China is in the midst of shifting from an economy that relies on manufacturing – to one that encourages innovation. Economists say that shift is opening up a world of possibilities for quick-thinking entrepreneurs from down under.

The key to Jess Wilson’s success came from an observation about the way she and other 20-something-year old consumers were being treated.

“I found that millennials weren’t being spoken to the right way when it came to shopping on your mobile so it’s something that I personally wanted.” Jess Wilson, founder of Stashd said.

To view the full article, please click on the button below.

Homepage > Biz Video

China’s economy shift attracts Australian focus

ReporterLiu Kai 丨 CCTV.com

10-25-2016 14:53 BJT

Australia is urging its businesses and companies to think innovatively when considering China. That’s because China is in the midst of shifting from an economy that relies on manufacturing – to one that encourages innovation. Economists say that shift is opening up a world of possibilities for quick-thinking entrepreneurs from down under.

The key to Jess Wilson’s success came from an observation about the way she and other 20-something-year old consumers were being treated.

Actinogen Medical Annual Report to Shareholders 2016

24th October 2016, ASX Announcement

Chaimans Address

It is a great pleasure on behalf of the Board to present the 2016 Actinogen Medical Annual Report. This year’s many achievements are the result of careful and prudent long-term strategic planning and our strong commitment to bring our distinctive novel drug Xanamem™ to market with a commercial focus on treating Alzheimer’s disease.

Xanamem™ represents a new approach to treating Alzheimer’s disease – a condition with a significant unmet medical need that threatens to place a huge burden on society. Xanamem works by blocking the development and regeneration of cortisol – the “stress hormone” – which appears to contribute to the cognitive impairment, amyloid plaques and neural death, that are the hallmarks of Alzheimer’s disease.

Alzheimer’s disease is one of the nation’s largest public health crises and has a debilitating effect on patients and their loved ones. Currently, Alzheimer’s is the second-leading cause of death in Australia according to the ABS, and sixth-leading cause of death in the United States.

To view the full announcement, please click on the button below.

Leaf Signs MOU with Malaysian Government Agency

25th October 2016, ASX Announcement

Highlights

  • Leaf Resources and its US-based joint development partner are working with two agencies of the Federal Government of Malaysia to further advance the development in Malaysia of at least one commercial-scale, second-generation, bio-chemical production facility.
  • Leaf has signed a Memorandum of Understanding with Agensi Inovasi Malaysia and a Letter of Facilitation and Collaboration with Malaysian Bioeconomy Development Corporation, both of which specify the objectives to be jointly undertaken by the parties to further advance Leaf’s project development efforts in Malaysia.
  • Leaf believes that Malaysia, with its abundant biomass resources, its advantageous location within the ASEAN region, and the active commitment of both the Federal and State Governments, presents a unique combination of all the attributes necessary to be a successful site for a “platform” Glycell™ production facility

Leaf Resources Ltd (ASX: LER, “Leaf”), together with Leaf Development, its US-based joint development partner, is pleased to announce the achievement of significant milestones related to the development in Malaysia of at least one commercial-scale, secondgeneration, bio-chemical production facility.

To view the full announcement, please click on the button below.

Stashd App Secures Deal with Online Shopping Giant Tencent

24th October 2016, The Australian By Glenda

Jessica Wilson, CEO and Founder of Stashd, has secured a deal with internet giant Tencent.

The largest app store in China, Tencent, has taken a 10 per cent stake in Stashd and TenCent Leilai will become a strategic shareholder to help with the localisation and expansion into China. Stashd will be assisted with local marketing teams, recruitment assistance, access to the market through their app store working from the TenCent Innovation Centre in China.

Tencent is the owner of the largest app store in China (700 million users) and the largest social network in China (WeChat). Stashd will integrate into WeChat and with WeChat pay for optimal localisation.

The deal was secured after Jessica a Sydney-based entrepreneur, featured as a global finalist in reality television show The Next Unicorn, a combination of Shark Tank and The Apprentice. The show also helped with the exposure of Stashd in China, with a viewing audience of more than 15 million Chinese. Stashd featured within the best new apps of the TenCent app store three weeks after launch.

The vision is to make Stashd the go-to app for Chinese millennials to shop western fashion.

To view the full article, please click on the button below.

Aeeris Annual Report to Shareholders 2016

24th October 2016, ASX Announcement

Highlights 2016 

  • FY16 was a transformation year for the Company following ASX listing on 1 April 2016
  • A year of continued gains in our core businesses and preparation of new product offerings to drive future revenue growth
  • Completed recruitment of key staff in software development, sales & marketing, finance, admin and operations, resulting in the company now having an integrated team for future growth
  • New customers and groundbreaking new technologies developed to diversify the Company’s revenue streams towards more quickly scalable products in the geospatial systems, data and content sectors
  • Sustained R&D efforts to develop these new software solutions for our corporate and enterprise customers, notably the SecureAMS product being rolled out for two major customers currently
  • Growing revenues across the customer base, expect for the decision to not renew a major (loss-making) contract, which has temporarily impacted top line revenues, but new higher margin products and customers are replacing this lost revenue

To view the full announcement, please click on the button below.

Tesserent Annual Report to Shareholders

21st October 2016, ASX Announcement

Our Company
Passionate About Security

Tesserent is a Melbourne based company providing managed cyber-security services to organisations throughout Australia and around the world. Our team of experts use the Tesserent proprietary security platform and a range of leading OEM products to tailor a network security solution specifically for our customers – on premise, in the cloud or via a secure connection. Tesserent provides specialised managed security services to direct customers while also offering a Managed Security Service Provider (MSSP) in-a-box solution as a wholesale offering to channel partners globally. Only Tesserent can provide our customers with the Tesserent platform, leading security technology and Tesserent’s 24/7/365 service and monitoring commitment.

Our Value
Proven Return on Investment

Tesserent is dedicated to offering our customers a cost-effective, world-class managed security solution. While we’re focused on optimising and securing our customers’ network, they’re free to focus on their business. Tesserent has a proven record of improving return on IT investment, driving efficiency and optimising network performance. We also bundle services including connectivity and colocation to optimise our customers’ network security and deliver a total solution.

To view the full announcement, please click on the button below.

Optus Satellite to Support Remote Worker Solutions with Aeeris Partnership

21st October 2016, ARN By Hafizah Osman

Optus Satellite has inked a partnership with ASX-listed company, Aeeris (ASX: AER), to support remote worker solutions such as the tracking of staff and delivery of communications services across Australia.

Specifically, managers will can track remote staff, receive and view check-ins and outs of locations, and be notified of ‘man down’ situations automatically and alert staff as required by either group or location based sending.

This will utilise Optus’ Satellite Services and the Thuraya SatSleeve .

Aeeris is a developer, operator and provider of the Early Warning Network (EWN), which is a multi-channel, Geographic Notification and Information System (GNIS) built to help protect lives, property and business.

To view the full announcement, please click on the button below.

Doug Rathbone Joins Board of Leaf Resources

21st October 2016, ASX Announcement

Leaf Resources Ltd (ASX: LER, “Leaf” or “the Company”) is pleased to announce the appointment of Mr.Doug Rathbone as a non exchange director of the Company commencing November 1, 2016.

Mr. Rathbone is currently Chairman of Rathbone Wine Group, a Director of Cotton Seed Distributors and AgBiTech, and a member of the Rabobank Advisory Board. He is a former Board member of CSIRO.

Mr. Rathbone, a chemical engineer by training, served as the Chief Executive Officer and Managing Director at Nufarm Limited from 1999 to 2015, and previously as the Managing Director of Nufarm Australia Limited from 1982.

To view the full announcement, please click on the button below.

Club Marine App Created by Aeeris Wins Award

21st October 2016, ASX Announcement

Aeeris is pleased to announce that the smartphone app developed by the Company for insurance client Club Marine has won the Innovation of the Year Award at the 2016 Australian Insurance Awards.

Club Marine is a company of Allianz Australia Insurance Limited.

This award is significant in placing Aeeris and Early Warning Network at the centre of digital innovation in the Australian insurance industry.

Aeeris’ platform provides a number of major insurers with complex data on sever weather events, bushfires and other geospatial hazards and is capable of helping these clients manage risk exposure.

To view the full announcement, please click on the button below.

Inside the New Zealand VR/AR Association’s Plan for Virtual World Domination

19th October 2106, idealog By Ben Mack

Some of New Zealand’s top VR and AR innovators have teamed up. Their goal: (virtual) world domination.

Aotearoa is a world-leader in a lot of things. Sheep. Kiwifruit. The most dominant sports team ever. Add virtual reality to that list.

The Land of the Long White Cloud’s top innovators in the booming virtual and augmented reality sector have joined forces to create the newly-formed New Zealand VR/AR Association. It’s part of a worldwide group of VR and AR innovators that has chapters in the United States, Canada, the United Kingdom and Asia, with a goal of accelerating growth, fostering research and education, developing industry standards, connecting member organisations, and promotimng services of member companies.

To view the full article, please click on the button below.

iSentric Annual Report to Shareholders 2016

21st October 2016, ASX Announcement

iSentric Limited (ASX : ICU) provides software based mobility platforms and services that enable its customers to extend their information technology applications to any mobile device and integrate mobile technology throughout their existing business. iSentric also works with telecommunication network providers to provide mobile OTT (over-the-top) services that leverage their subscriber base to build active communities.

  • iSentric operates in the mobile services industry through three main divisions:
  • Digital Payments – a mobile payment platform that enable consumers to make small financial transactions;
  • Enterprise Mobility – a platform that delivers mobile connectivity, messaging and mobile banking to corporate clients; and
  • Digital Media and Services which consists of an online mobile content aggregation platform and a proprietary game publishing network offering online games, mobile games, news and events.

To view the full announcement, please click on the button below.

Bupa Supports MedAdvisor with Patients Leaving Hospital

20th October 2016, ASX Announcement

Highlights

  • MedAdvisor has extended its existing relationship with Bupa into certain Healthscope Hospitals, via the “Always Events” agreement
  • MedAdvisor platform is now being offered to Bupa patients as they are discharged from certain Healthscope Hospitals to help manage their medications as they return home
  • 12% of all admissions to hospital are medication related, increasing to 20-30% for over 65 year olds
  • Partnership helps encourage the transition from hospital to home, providing substantial health system benefits
  • Strong market validation for the Company’s technology platform and strengthens value proposition as a market leading provider of medication management software

MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that it has extended its partnership with Bupa Australia and New Zealand. As part of the Healthscope and Bupa program called ‘Always Events’ which tackles the issue of medication-related hospital readmissions, the Company’s platform will be offered to Bupa patients on discharge from certain Healthscope owned hospitals.

To view the full announcement, please click on the button below.

Meme Fund Achieves Platform Ratings

On establishing our 3 year track record after July this year, the Meme Australian Share Fund began to be reviewed by a number of data platforms and performance ratings have already been provided in a number of instances.

We are very proud to announce the following results so far:

The Meme Australian Share Fund is a boutique fund which invests in ASX listed equities outside the ASX20.  The Fund employs systematic quantitative strategies to identify and invest in stocks which are providing both positive absolute performance and relative out-performance over the broad ASX universe.

The Fund is currently open to new investment.

Proteomics Targets Gastro-Causing Parasite

20th October 2016, ASX Announcement

Perth life sciences company Proteomics International Laboratories Ltd (PILL, ASX: PIQ) has successfully applied its biomarker discovery platform Promarker to the parasite Giardia.

  • PILL maps samples from the gastro-causing parasite Giardia.
  • Giardiasis is one of the most common waterborne diseases worldwide.
  • Secures commercial funding and Federal Entrepreneurs’ Programme grant to help commercialise the test.
  • PILL to receive a royalty stream from net sales for any diagnostic test.

PILL used the company’s proprietary technology to map samples of the gastro-causing parasite, searching for protein ‘fingerprints’ that can distinguish between different strains.

The proof-of-concept study was conducted in collaboration with Murdoch University and on a feefor-service basis with a leading US veterinary company. This collaboration will now be extended with the aim to develop a commercial diagnostic test for Giardia, and a licence agreement is in place to ensure PILL receives a royalty stream from sales of any test.

To view the full announcement, please click on the button below.

Vinomofo Goes Big in First Mass-Media Brand Campaign

19th October 2016, Marketing Mag By Ben Ice

Vinomofo has released an epic short film and new tagline, ‘Decide’.

On the back of securing $25 million investment from Blue Sky Capital, online wine retailer Vinomofo secured film industry ‘gurus’ and filmed a short film in New Zealand as the basis for its first ever mass-media brand campaign.

The ‘Decide’ campaign is by far the largest campaign to date for the brand, which is spending $4.5 million on a multi-platform strategy between now and the end of the year. Previously Vinomofo has relied primarily on social media and digital marketing.

To view the full article, please click on the button below.

MedAdvisor Completes $8M Oversubscribed Capital Raising

19th October 2016, ASX Announcement

Highlights

  • MedAdvisor has successfully raised $8 million via an institutional placement (Placement)
  • Placement was significantly oversubscribed, with strong support from both existing and new shareholders
  • Strong participation from leading Australian institutions and pharmacies, providing further industry validation and recognition
  • Funding will be used to complete the acquisition of Healthnotes, strengthening MedAdvisor’s market position and to fuel additional growth initiatives and scale

MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication management company, is pleased to announce offers have been accepted to raise $8 million via an institutional placement (Placement).

200 million new fully paid ordinary shares, raising a total of $8 million, will be issued at $0.04 per share representing no discount to the 5 day VWAP and a discount of 10% to the last traded price.

To view the full announcement, please click on the button below.

Omni Market Tide Sings Agreement to Acquire RightCrowd and Capital Raise

19th October 2016, ASX Announcement

  • Agreed pre-acquisition value contribution of OMT at 8.18%;RightCrowd at 91.82%
  • $35 million capital raising under a prospectus (subject to shareholder approval) at a price which implies a pre-money valuation of at least $85 million for the merged OMT and RightCrowd entity
  • Mandate with Morgans for capital raising
  • Consolidation of all OMT securities on a 10:1 basis (subject to shareholder approval)
  • Appointment of Peter Hill to the board (subject to shareholder approval)
  • Change in nature and scale of OMT’s activities (subject to shareholder approval)
  • Name change to RightCrowd Limited (subject to shareholder approval)
  • Re-compliance with Chapters 1 and 2 of the ASX Listing Rules

1. Introduction

The Board of Omni Market Tide Limited (Company or OMT) is pleased to announce today that it has entered into a Share Sale and Purchase Agreement (Agreement) to acquire Sentrii Pty Ltd ACN 108 411 427 (Sentrii) and the RightCrowd business (RightCrowd) (Acquisition).

To view the full announcement, please click on the button below.

Altech Chemicals Company Presentation October 2016

18th October 2016, ASX Announcement

Sapphire Gemstone

  • Sapphire & Ruby
  • Natural form of high purity alumina (HPA)
  • Formed by mother nature like diamonds
  • Colour from impurities
  • Nearly as hard as diamond (Moh 9)

What’s HPA?

  • Purified alumina
  • Greater than 99.99% (4N) purity
  • Smelter Grade Alumina (SGA) ~ 99.5% (5,000 ppm impurities mainly sodium)
  • Bayer Process uses sodium hydroxide (NaOH)
  • Sodium impurity is problem for electronics industry

To view the full Presentation, please click on the button below.

OncoSil Medical CEO Presentation & AGM October 2016

18th October 2016, ASX Announcement

Achievements Delivered FY16

September 2015 – Submission of CE Mark application for OncoSil™

October 2015 - OncoSil™ CE Mark application granted Fast Track review status

December 2015 – Investigational Device Exemption submitted to the FDA for OncoPac-1 clinical study

January 2016 – Chris Roberts appointed Independent Non-Executive Director

February 2016 – $10 million private placement to Regal Funds Management

March – April 2016 – Q-Submissions meeting with FDA
-Responses to CE Mark and FDA questions

May 2016 - OncoSil Medical completes hiring of senior management for the Leadership Team

June 2016 – IDE Amendment submitted to the FDA for OncoPac-1 clinical study

To view the full Presentation, please click on the button below.

Altech Chemicals Makes Solid Progress with HPA Project

18th October 2016, ASX Announcement

Highlights:

  • HPA project due diligence nearing completion
  • No fatal flaws identified
  • Detailed design progressing as planned
  • Permitting for Malaysian HPA plant construction commenced

Altech Chemicals Limited (Altech/the Company) (ASX:ATC) is pleased to provide an update on its HPA project, which comprises the proposed construction of a 4,000tpa high purity alumina (HPA) plant at Johor, Malaysia and a kaolin quarry and container loading faciility at Meckering, Western Australia (the Project).

To view the full announcement, please click on the button below.

DomaCom Poised to List on the ASX

Crowdfunder DomaCom is poised to list on the ASX in the next few weeks, having raised $7.35 million of a targeted $10 million to underpin its next growth phase.

DomaCom CEO Arthur Naoumidis says that subject to some administrative issues, everything is on track to meet the official closing date on 23 October. [Share applications need to be in by 5pm on 21 October to enable processing.]

“We are very pleased with the result of our capital raising that has increased total shareholder numbers to nearly 700.

The injection of capital from this IPO will position DomaCom for its next growth phase – to build on the 59 property bookbuilds currently in progress, adding to the 24 properties already acquired.

We are active across the residential sector with existing and new development property and also have two rural properties set to launch,” says Naoumidis.

In addition to these projects, DomaCom is engaged in bookbuilding The Block apartments featured on the Channel 9 program and is working on a regional city town square development at Mount Barker, on the outskirts of Adelaide.

About DomaCom

DomaCom Australia Limited ACN 153 951 770  launched Australia’s first online fund to provide a property investment solution for the SMSF market and other long term investors through the fractional acquisition of units in a unique trust structure that enables investors to choose the property they want.  Residential and commercial property Australia wide, can be accessed in this Fund from vendors and developers and available as individual properties or in multi-property model portfolios. DomaCom is also currently working towards an equity release product and intends to extend the technology to provide this solution for senior Australians to access much needed capital, whilst affording the next generation an opportunity for income and capital growth through property.

Real Estate Investar Annual Report to Shareholders

17th October 2016, ASX Annoucement

Progress

Real Estate Investar Group Limited listed on the Australian Stock Exchange on 10 December 2015.

Since then we have made progress in the following:

  • 31.7% increase in income
  • 52 properties sold to members during the year
  • 200,00+ member; 48% year on year increase in members
  • $5 million raised on completion of IPO

To view the full announcement, please click on the button below.